<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1053532</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2022.1053532</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Synthesis, characterization, and biological activities of zinc(II), copper(II) and nickel(II) complexes of an aminoquinoline derivative</article-title>
<alt-title alt-title-type="left-running-head">Damena et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2022.1053532">10.3389/fchem.2022.1053532</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Damena</surname>
<given-names>Tadewos</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2023834/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alem</surname>
<given-names>Mamaru Bitew</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1975372/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zeleke</surname>
<given-names>Digafie</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2029193/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Desalegn</surname>
<given-names>Tegene</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1995550/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eswaramoorthy</surname>
<given-names>Rajalakshmanan</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1995359/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Demissie</surname>
<given-names>Taye B.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1601427/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Applied Chemistry</institution>, <institution>Adama Science and Technology University</institution>, <addr-line>Adama</addr-line>, <country>Ethiopia</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Chemistry</institution>, <institution>Wachemo University</institution>, <addr-line>Hossana</addr-line>, <country>Ethiopia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Chemistry</institution>, <institution>Salale University</institution>, <addr-line>Fitche</addr-line>, <country>Ethiopia</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Biomaterials</institution>, <institution>Saveetha University</institution>, <addr-line>Chennai</addr-line>, <country>India</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Chemistry</institution>, <institution>University of Botswana</institution>, <addr-line>Gaborone</addr-line>, <country>Botswana</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/74958/overview">Lu&#xed;s D. Carlos</ext-link>, University of Aveiro, Portugal</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1767005/overview">Musa A. Said</ext-link>, Taibah University, Saudi Arabia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1165378/overview">Renjith Thomas</ext-link>, Mahatma Gandhi University, India</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1695923/overview">Ashutosh Nath</ext-link>, University of Massachusetts Boston, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Tadewos Damena, <email>btadeows@gmail.com</email>; Tegaene Desalegn, <email>tegened@yahoo.com</email>; Taye B.Demissie, <email>sene3095@gmail.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>ORCID: Tadewos Damena, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-5345-002X">orcid.org/0000-0001-5345-002X</ext-link>; Tegene Desalegn, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-0239-8326">orcid.org/0000-0003-0239-8326</ext-link>; Taye B. Demissie, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-8735-4933">orcid.org/0000-0001-8735-4933</ext-link>
</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Inorganic Chemistry, a section of the journal Frontiers in Chemistry</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>11</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>1053532</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>09</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>10</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Damena, Alem, Zeleke, Desalegn, Eswaramoorthy and Demissie.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Damena, Alem, Zeleke, Desalegn, Eswaramoorthy and Demissie</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Interest is increasingly focused on the use of transition metal complexes as biochemical, medical, analytical, pharmaceutical, agronomic, anticancer, and antibacterial agents. In this study, three complexes of [Zn(H<sub>2</sub>L)Cl] (<bold>1</bold>), [Cu(H<sub>2</sub>L)(H<sub>2</sub>O)(NO<sub>3</sub>)] (<bold>2</bold>) and [Ni(H<sub>2</sub>L)(NO<sub>3</sub>)].2H<sub>2</sub>O (<bold>3</bold>) were synthesized from a 2-chloroquinoline-3-carbaldehyde derived ligand [H<sub>3</sub>L &#x3d; ((<italic>E</italic>)-2-(((2-((2-hydroxyethyl)amino)quinolin-3-yl)methylene)amino)ethanol. The compounds were characterized using physicochemical and spectroscopic methods. The results demonstrate that the free ligand behaves as a tridentate ligand with one oxygen and two nitrogen (ONN) donor atoms in 1:1 metal:ligand ratio. The formation constants of the complexes were found to be (<italic>K</italic>
<sub>Zn(II)</sub> &#x3d; 2.3 &#xd7; 10<sup>6</sup>, <italic>K</italic>
<sub>Cu(II)</sub> &#x3d; 2.9 &#xd7; 10<sup>6</sup>, <italic>and K</italic>
<sub>Ni(II)</sub> &#x3d; 3.8 &#xd7; 10<sup>5</sup>). The thermodynamic parameters indicated that the reactions were spontaneous with exothermic nature of metal-ligand interaction energies. Based on the analyses of the experimental (EDX, FTIR, PXRD, MS and TGA) and DFT results, a distorted tetrahedral, a distorted square pyramidal and square planar geometry for Zn(II), Cu(II) and Ni(II) complexes, respectively, were proposed. The B3LYP calculated IR frequencies and TD-B3LYP calculated absorption spectra were found to be in good agreement with the corresponding experimental results. The powder XRD data confirmed that the Zn(II), Cu(II) and Ni(II) complexes have polycrystalline nature with average crystallite sizes of 27.86, 33.54, 37.40&#xa0;&#xc5;, respectively. <italic>In vitro</italic> antibacterial activity analyses of the complexes were studied with disk diffusion method, in which the complexes showed better activity than the precursor ligand. Particularly the Cu(II) complex showed higher percent activity index (62, 90%), than both Zn(II) (54, 82%) and Ni(II) (41, 68%) complexes against both <italic>E. coli</italic> and <italic>P. aeruginosa</italic>, respectively. Using the DPPH assay, the complexes were further assessed for their antioxidant capacities. All metal complexes showed improved antioxidant activity than the free ligand. Zn(II) and Cu(II) complexes, which had IC<sub>50</sub> values of 10.46 and 8.62&#xa0;&#x3bc;g/ml, respectively, showed the best antioxidant activity. The calculated results of Lipinski&#x2019;s rule of five also showed that the target complexes have drug-like molecular nature and similarly, the results of binding mode of action of these compounds against <italic>E. coli</italic> DNA gyrase B and <italic>P. aeruginosa</italic> LasR.DNA were found to be in good agreement with the <italic>in vitro</italic> biological activities.</p>
</abstract>
<kwd-group>
<kwd>aminoquinoline</kwd>
<kwd>novel metal complexes</kwd>
<kwd>DFT analysis</kwd>
<kwd>molecular docking</kwd>
<kwd>antibacterial</kwd>
<kwd>antioxidant</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>The application of transition metal complexes as biochemical, medicinal, analytical, pharmaceutical, agricultural, antitumor and antimicrobial agents has become center of interest for researchers (<xref ref-type="bibr" rid="B31">Fetoh et al., 2018</xref>; <xref ref-type="bibr" rid="B37">Hamdani and Amane, 2019</xref>; <xref ref-type="bibr" rid="B73">Sumalatha et al., 2021</xref>). Recently, huge focus is being geared towards the chemistry of coordination compounds due to the inherent potential of metals and their organic based complexes for treatment of various health problems and disorders (<xref ref-type="bibr" rid="B31">Fetoh et al., 2018</xref>; <xref ref-type="bibr" rid="B37">Hamdani and Amane, 2019</xref>). In this regard, the syntheses of biologically active complexes have paramount significance. Research results over the past decades have witnessed that metal complexes were found to exhibit potential antimicrobial and antioxidant (<xref ref-type="bibr" rid="B27">El-Gammal et al., 2021</xref>; <xref ref-type="bibr" rid="B43">Kargar et al., 2021</xref>; <xref ref-type="bibr" rid="B44">Kaya et al., 2021</xref>; <xref ref-type="bibr" rid="B20">Damena et al., 2022a</xref>), antiviral (<xref ref-type="bibr" rid="B10">Atasever Arslan et al., 2021</xref>), anticancer (<xref ref-type="bibr" rid="B53">Malik et al., 2021</xref>), antidiabetic (<xref ref-type="bibr" rid="B46">Kole&#x161;a-Dobravc et al., 2018</xref>) and cytotoxicity (<xref ref-type="bibr" rid="B5">Alem et al., 2022</xref>) activities. In this aspect, the ongoing search for natural products with potential biologically active ligands have confirmed that quinoline and its derivative ligands lie among the important classes of biologically active ligands. Such ligands have become interesting due to their extensive pharmacological properties and applications, such as anticancer (<xref ref-type="bibr" rid="B32">Fouda, 2017</xref>), antifungal and antiprotozoal (<xref ref-type="bibr" rid="B65">Ram&#xed;rez&#x2013;Prada et al., 2017</xref>), anti-inflammatory (<xref ref-type="bibr" rid="B61">Pinz et al., 2017</xref>), antidiabetic (<xref ref-type="bibr" rid="B57">Murugavel et al., 2017</xref>), antimicrobial (<xref ref-type="bibr" rid="B58">Nagesh et al., 2015</xref>; <xref ref-type="bibr" rid="B25">Digafie et al., 2021</xref>; <xref ref-type="bibr" rid="B20">Damena et al., 2022a</xref>), and antioxidant activities (<xref ref-type="bibr" rid="B25">Digafie et al., 2021</xref>; <xref ref-type="bibr" rid="B36">Halevas et al., 2021</xref>; <xref ref-type="bibr" rid="B20">Damena et al., 2022a</xref>).</p>
<p>Previous studies show that zinc complexes exhibit antidiabetic (<xref ref-type="bibr" rid="B46">Kole&#x161;a-Dobravc et al., 2018</xref>), antioxidant (<xref ref-type="bibr" rid="B36">Halevas et al., 2021</xref>; <xref ref-type="bibr" rid="B20">Damena et al., 2022a</xref>), and antimicrobial activities (<xref ref-type="bibr" rid="B58">Nagesh et al., 2015</xref>; <xref ref-type="bibr" rid="B20">Damena et al., 2022a</xref>), whereas copper (II) and nickel (II) complexes have antimicrobial, antioxidant, DNA binding, and antiviral activities (<xref ref-type="bibr" rid="B78">Zou et al., 2017</xref>; <xref ref-type="bibr" rid="B10">Atasever Arslan et al., 2021</xref>; <xref ref-type="bibr" rid="B27">El-Gammal et al., 2021</xref>; <xref ref-type="bibr" rid="B43">Kargar et al., 2021</xref>). However, the structural and biological properties of metal complexes with imine containing N-heterocyclic ligand, [H<sub>3</sub>L&#x3d; ((<italic>E</italic>)-2-(((2-((2-hydroxyethyl)amino)quinolin-3-yl)methylene)amino)ethanol, have not been reported. Hence, we hereby report the synthesis of these metal complexes from the corresponding metal salts (zinc chloride, copper nitrate trihydrate, and nickel nitrate hexahydrate with their biological (antibacterial and antioxidant) properties using disc diffusion and DPPH assay methods, respectively. Furthermore, computational studies had been performed to better understand the properties and activities of the complexes and to correlate with the experimental results.</p>
</sec>
<sec id="s2">
<title>2 Experimental methods</title>
<sec id="s2-1">
<title>2.1 Materials</title>
<p>Acetic anhydride 99.8%, acetic acid glacial 99.5%, aniline 99%, N, N- dimethyl formamide 99%, phosphorus oxychloride 98%, methanol 99.5%, n-Hexane 99%, dichloromethane 98%, Ethyl acetate 99.5%, chloroform 99%, Triethylamine 99%, copper nitrate trihydrate 98%, nickel nitrate hexahydrate 98%, zinc chloride 98%, silver nitrate 99.9%, L-Ascorbic acid 99%, Dimethyl sulphoxide 99% and 2, 2-diphenyl-1-picrylhydrazyl (DPPH) were used. All the chemicals and reagents, analytical grade, were purchased from Loba chemie PVT. LtD (Mumbai, India).</p>
</sec>
<sec id="s2-2">
<title>2.2 Characterization techniques</title>
<p>The NMR spectra of the ligand were obtained using NMR Bruker Avance 400 spectrometer operating at 400&#xa0;MHz using DMSO-d6 and CDCl<sub>3</sub>. Chemical shifts (&#x3b4;) are reported in ppm and the coupling constants (<italic>J</italic>) are reported in Hz. Fluorescence and UV-visible spectral data were measured using Agilent MY-18490002/PC spectrofluorophotometer and SM-1600 Spectrophotometer, respectively. The absorption spectra of the synthesized compounds were measured using 1.0 &#xd7; 10<sup>&#x2013;5</sup>&#xa0;M methanolic diluted solution. Elemental composition and morphology were carried out using scanning electron microscopy with energy dispersive X-ray (SEM-EDX, CARL ZE 155, OXFORD instrument&#x2019;s EDX, USA Hitachi SU 70 Oxford Instruments 50&#xa0;mm<sup>2</sup> X-Max silicon drift EDS detector, with resolution of 127&#xa0;eV FWHM and detection limit of about 1 atomic % from depth of 0.3&#x2013;3&#xa0;&#x3bc;m). Mass spectra were recorded with SHIMADZU, LC-MS 8030 (model LCMS-8030, mass range <italic>m/z</italic> 10 to 2000, sensitivity resolution R &#x3c; 0.7 FWHM). X-ray diffractometer (SHIMADZU model: XRD-7000 X-RAY DIFFRACTOMETER) was used to measure the X-ray diffraction. The patterns of the synthesized metal complexes were performed using powder sample with measurement conditions of X-ray tube target: Cu (<italic>&#x3bb;</italic> &#x3d; 1.5406&#xa0;&#xc5;), voltage: 40.0&#xa0;kV, current: 30.0&#xa0;mA, divergence slit: 1.0<sup>o</sup>, scatter slit: 1.0<sup>o</sup>, receiving slit: 0.3&#xa0;mm, scanning drive axis: 2&#x3b8;, scan range: 5.0&#x2013;80.0<sup>o</sup>, scan mode: continuous scan, Scan speed: 3.0&#xa0;<sup>o</sup>/min, sampling pitch: 0.02<sup>o</sup>.</p>
<p>The Chekcell Graphical Powder Indexing (CCP14) program was used to calculate the miller indices, whereas the lattice parameters were determined using the CRYSFIR computer program. FTIR measurements were performed using Perkin-Elmer BX spectrometer (from 4000&#x2013;400&#xa0;cm<sup>&#x2212;1</sup> and KBr pellets). Thermogravimetric analyses (TGA) data were recorded using DTG-60H SHIMADZU thermal analyzer under nitrogen-atmosphere (20&#xa0;ml/min) and heating rate of 10<sup>&#xb0;</sup>C/min between 25&#x2013;800&#xb0;C. Molar conductance of the complexes were recorded at room temperature in 1 &#xd7; 10<sup>&#x2013;3</sup>&#xa0;M methanolic solution of the samples using conductometre (AD8000: resolution 0.1&#xa0;mV (&#xb1;699.9&#xa0;mV)/1&#xa0;mV (&#xb1;2000&#xa0;mV), 0.01, 0.1, 1&#xa0;&#x3bc;S/cm; ppm, 0.01, 0.1&#xa0;mS/cm; ppt 0.1&#xb0;C, accuracy at 25&#xb0;C &#xb1; 0.2&#xa0;mV up to &#xb1;699.9&#xa0;mV, &#xb1; 1&#xa0;mV up to &#xb1;2000&#xa0;mV), &#xb1;0.5&#xb0;C). Melting point analysis was performed using digital auto melting point apparatus (Hanchen, model 934).</p>
</sec>
<sec id="s2-3">
<title>2.3 General procedure for the synthesis of the ligand (H<sub>3</sub>L)</title>
<p>The ligand was prepared based on our previously reported procedure (<xref ref-type="bibr" rid="B25">Digafie et al., 2021</xref>) with minor modifications, in which 2-chloroquinoline-3-carbaldehyde (2.5&#xa0;g, 0.013&#xa0;mol) was added to 15&#xa0;ml ethanol amine and refluxed at temperature ranges of 90&#x2013;95&#xb0;C for 2&#xa0;h. The progress and completion of the reaction was monitored using TLC. After completion, the resulting mixture was cooled and then put into crushed ice. The precipitate was collected through suction filtration and washed with ice cold water to remove the excess amount of ethanolamine which served both as solvent and reagent as well as unreacted material, and finally dried at room temperature (<xref ref-type="bibr" rid="B25">Digafie et al., 2021</xref>). The ligand has a molecular formula of C<sub>14</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>, with a yield 86% and yellow powder and melting point of 80&#x2013;85&#xb0;C. It has UV-Visible &#x3bb;<sub>max</sub> (methanol) of 383&#xa0;nm, IR [&#x28b; cm<sup>&#x2212;1</sup>, KBr (pellet)]: 3368 &#x3bd;(O-H), 3275 &#x3bd;(N-H), 1639 &#x3bd;(imine C&#x3d;N). Composition: Calc. for C<sub>14</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>; C 64.85; H 6.61; N 16.20; O 12.34%. Found C 64.71; H 6.65; N 16.08 and O 12.56%. <sup>1</sup>H NMR (400&#xa0;MHz, DMSO-d6): <italic>&#x3b4;</italic>
<sub>H</sub> 3.65 (8H, <italic>d</italic>, H-11, H-12, H-14 and H-15), 4.72 (1H, <italic>s</italic>, OH), 4.92 (1H, <italic>s</italic>, OH), 7.19 (1H, <italic>t</italic>, <italic>J</italic> &#x3d; 7.25Hz, H-6), 7.55 (2H, <italic>m</italic>, H-5, H-8), 7.72 (1H, <italic>d</italic>, <italic>J</italic> &#x3d; 8.36 Hz, H-7), 8.21 (1H, <italic>s</italic>, H-4), 8.5(1H, <italic>s</italic>, H-9), and 9.55 (1H, <italic>s</italic>, NH); <sup>13</sup>C NMR (400&#xa0;MHz, DMSO-d6): <italic>&#x3b4;</italic>
<sub>C</sub> 43.4 (C-14), 60.5 (C-12), 61.2 (C-15), 63.7 (C-11), 117.2 (C-3), 121.9 (C-8), 122.4 (C-4a), 125.7 (C-5), 128.9 (C-6), 131.5 (C-7), 143.0 (C-4), 148.3 (C-8a), 155.4 (C-2), and 163.8 (C-9); DEPT-135 &#x3b4;C 43.4 (C-14 negative), 60.5 (C-12 negative), 61.2 (C-15 negative), 63.7 negative (C-11), 121.9 (C-8), 125.7 (C-5), 128.9 (C-6), 131.5 (C-7), 143.0 (C-4) and 163.8 (C-9). Composition: Calc. for C<sub>14</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>; C 64.85; H 6.61; N 16.20; O 12.34%. Found C 64.71; H 6.65; N 16.08 and O 12.56% (<xref ref-type="sec" rid="s10">Supplementary Figures S1&#x2013;S3, S4B</xref>).</p>
</sec>
<sec id="s2-4">
<title>2.4 Synthesis of the metal complexes</title>
<p>A drop of triethylamine was added to stirred solution of the ligand (0.25 g, 0.96&#xa0;mmol,) in methanol (10&#xa0;ml). After 30&#xa0;min of stirring, a solution (0.96&#xa0;mmol) of ZnCl<sub>2</sub> (0.13&#xa0;g), Cu(NO<sub>3</sub>)<sub>2</sub>&#xb7;3H<sub>2</sub>O (0.232&#xa0;g), and Ni(NO<sub>3</sub>)<sub>2</sub>.6H<sub>2</sub>O (0.279&#xa0;g) in methanol (10&#xa0;ml,) was added dropwise to this solution separately in different flasks (<xref ref-type="bibr" rid="B20">Damena et al., 2022a</xref>; <xref ref-type="bibr" rid="B22">Damena et al., 2022b</xref>). The mixture was refluxed for 3&#xa0;h and 3.5&#xa0;h at 80&#xb0;C, respectively for the Zn(II), Cu(II) and Ni(II) complexes. Progress and completion of the reaction was monitored with thin layer chromatography. After completion, the reaction mixture was cool down at room temperature and the precipitated product was filtered off, washed with ice cold methanol and dried at room temperature based on reported procedures (<xref ref-type="bibr" rid="B78">Zou et al., 2017</xref>; <xref ref-type="bibr" rid="B62">Ramachandran et al., 2018</xref>; <xref ref-type="bibr" rid="B59">Naz et al., 2020</xref>; <xref ref-type="bibr" rid="B36">Halevas et al., 2021</xref>; <xref ref-type="bibr" rid="B73">Sumalatha et al., 2021</xref>; <xref ref-type="bibr" rid="B20">Damena et al., 2022a</xref>). Finally, light yellow, deep green and reddish brown powder product was obtained respectively (<xref ref-type="sec" rid="s10">Supplementary Figure S5</xref>). The proposed reaction mechanisms are presented in <xref ref-type="scheme" rid="sch1">Scheme 1</xref>.</p>
<fig id="sch1" position="float">
<label>SCHEME 1</label>
<caption>
<p>Proposed synthetic reactions of <bold>(A)</bold> ligand (H<sub>3</sub>L) and <bold>(B)</bold> its metal complexes.</p>
</caption>
<graphic xlink:href="FCHEM_fchem-2022-1053532_wc_sch1.tif"/>
</fig>
<sec id="s2-4-1">
<title>2.4.1 Complex 1</title>
<p>Complex <bold>1</bold> was found to be light yellow polycrystalline powder with molecular formula [Zn(H<sub>2</sub>L)Cl], yield 63%, melting point 225&#x2013;230&#xb0;C. It is soluble in polar solvents. Compositions calculated for <bold>1</bold> are C 46.82, H 4.49, N 11.70, O 8.91, Cl 9.87 and Zn 18.21%; found: C 46.85, H 4.36, N 11.80, O 8.55, Cl 10.25 and Zn 18.19%. FTIR (&#x28b; cm<sup>&#x2212;1</sup>, KBr (pellet)): 1657 &#x3bd;(Imin C&#x3d;N), 1034 &#x3bd;(C-O), 524 &#x3bd;(Zn-O), and 460 &#x3bd;(Zn-N). UV-Vis (methanol, nm): 231 (&#x3c0;&#x2192;&#x3c0;&#x2a;), 258 (&#x3c0;&#x2192;&#x3c0;&#x2a;), 300 (n&#x2192;&#x3c0;&#x2a;) and 380 (n&#x2192;&#x3c0;&#x2a;).</p>
</sec>
<sec id="s2-4-2">
<title>2.4.2 Complex 2</title>
<p>Complex <bold>2</bold> was found to be deep green polycrystalline powder with molecular formula [Cu(H<sub>2</sub>L)(H<sub>2</sub>O)(NO<sub>3</sub>)], yield 61.5%, melting point 195&#x2013;200&#xb0;C. It is soluble in polar solvents. Compositions calculated for <bold>2</bold> are C 41.84, H 4.51, N 13.94, O 23.89 and Cu 15.81%; found: C 41.62, H 4.90, N 13.80, O 24.15, and Cu 15.53%. FTIR (&#x28b; cm<sup>&#x2212;1</sup>, KBr (pellet)): 1652 &#x3bd;(Imin C&#x3d;N), 1059 &#x3bd;(C-O), 626 &#x3bd;(Cu-O), and 474 &#x3bd;(Cu-N). UV-Vis (methanol, nm): 235 (&#x3c0;&#x2192;&#x3c0;&#x2a;), 267 (n&#x2192;&#x3c0;&#x2a;), 317 (n&#x2192;&#x3c0;&#x2a;) and 406 (LMCT).</p>
</sec>
<sec id="s2-4-3">
<title>2.4.3 Complex 3</title>
<p>Complex <bold>3</bold> was found to be brownish purple polycrystalline powder with molecular formula [Ni(H<sub>2</sub>L)(NO<sub>3</sub>)].2H<sub>2</sub>O, yield 66%, melting point 115&#x2013;120&#xb0;C. It is soluble in polar solvents. Compositions calculated for <bold>3</bold> are C 40.52, H 4.86, N 13.50, O 26.99 and Ni 14.14%; found: C 40.86, H 4.95, N 13.35, O 26.90 and Ni 13.94%. FTIR (&#x28b; cm<sup>&#x2212;1</sup>, KBr (pellet)): 1650 &#x3bd;(Imin C&#x3d;N), 1037 &#x3bd;(C-O), 534 &#x3bd;(Ni-O), and 462 &#x3bd;(Ni-N). UV-Vis (methanol, nm): 229 (&#x3c0;&#x2192;-&#x3c0;&#x2a;), 259 (&#x3c0;&#x2192;&#x3c0;&#x2a;), 302 (n&#x2192;&#x3c0;&#x2a;) and 401 (LMCT).</p>
</sec>
</sec>
<sec id="s2-5">
<title>2.5 Formation constants and thermodynamic parameters</title>
<p>Zn(II) chloride, Cu(II) nitrate trihydrate, and Ni(II) nitrate hexahydrate standard solutions were pipetted into ten 50&#xa0;ml volumetric flasks (0, 1, 2,... 10&#xa0;ml), and aliquots of a similar standard solution of the precursor ligand were added (10, 9, 8... 0&#xa0;ml). All absorbance were recorded at &#x3bb;<sub>max</sub> 380, 406, and 401&#xa0;nm, respectively, for complexes <bold>1</bold>, <bold>2</bold> and <bold>3</bold>, at temperatures of 25, 30, 37 and 40&#xb0;C. A drop of triethylamine was used to keep the pH of the mixture constant. The metal ion and free ligand mole fractions were changed between 0 and 1 for stoichiometric measurement. From this, the absorbance of the solutions was plotted with these mole fractions, and &#x201c;n&#x201d;, the average number of bound ligand, was obtained from the plot, where <italic>X</italic>
<sub>max</sub> was calculated using <xref ref-type="disp-formula" rid="e1">Eq. 1</xref> (<xref ref-type="bibr" rid="B4">Ahmad et al., 2012</xref>; <xref ref-type="bibr" rid="B71">Shalaby and Mohamed, 2020</xref>).<disp-formula id="e1">
<mml:math id="m1">
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:msub>
<mml:mi>X</mml:mi>
<mml:mi mathvariant="italic">max</mml:mi>
</mml:msub>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>X</mml:mi>
<mml:mi mathvariant="italic">max</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<label>(1)</label>
</disp-formula>
</p>
<p>Additionally, spectroscopic analysis was used to estimate the complexes&#x2019; formation constants (<xref ref-type="sec" rid="s10">Supplementary Eq. S1</xref>). The changes in enthalpy and entropy (&#x394;<italic>H</italic> and &#x394;<italic>S</italic>) were derived from the slope and intercept of the lnK vs. 1/T (van&#x2019;t Hoff) plot, respectively, in order to evaluate the thermodynamic parameters (&#x394;<italic>G</italic>, &#x394;<italic>H</italic>, and &#x394;<italic>S</italic>) appropriately (<xref ref-type="bibr" rid="B4">Ahmad et al., 2012</xref>; <xref ref-type="bibr" rid="B21">Damena et al., 2014</xref>; <xref ref-type="bibr" rid="B71">Shalaby and Mohamed, 2020</xref>). <xref ref-type="disp-formula" rid="e3">Eqs 2, 3</xref> were combined to get the reactions&#x2019; Gibbs free energy (&#x394;<italic>G</italic>).<disp-formula id="e2">
<mml:math id="m2">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#x394;</mml:mo>
<mml:mi mathvariant="normal">H</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi mathvariant="normal">T</mml:mi>
<mml:mo>&#x394;</mml:mo>
<mml:mi mathvariant="normal">S</mml:mi>
</mml:mrow>
</mml:math>
<label>(2)</label>
</disp-formula>
<disp-formula id="e3">
<mml:math id="m3">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">T</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>ln</mml:mi>
<mml:mo>&#x2061;</mml:mo>
<mml:mi mathvariant="normal">K</mml:mi>
</mml:mrow>
</mml:math>
<label>(3)</label>
</disp-formula>
</p>
</sec>
<sec id="s2-6">
<title>2.6 Antibacterial activity</title>
<p>Antibacterial activities of the newly synthesized Zn(II), Cu(II) and Ni(II) complexes (<bold>1</bold>&#x2013;<bold>3</bold>) were evaluated using disc diffusion method against two Gram-positive (<italic>Staphylococcus aureus</italic>, ATCC25923 and <italic>Streptococcus pyogenes</italic>, ATCC19615) and two Gram-negative (<italic>Escherichia coli</italic>, ATCC 25922, and <italic>Pseudomonas aeruginosa</italic>, ATCC 27853) bacteria by following previously reported media preparation methods (<xref ref-type="bibr" rid="B20">Damena et al., 2022a</xref>; <xref ref-type="bibr" rid="B22">Damena et al., 2022b</xref>). The antibacterial activities were recorded for two sample concentrations (150 and 300&#xa0;<italic>&#x3bc;</italic>g/ml) in DMSO. Ciprofloxacin and DMSO were used as a positive and negative control, respectively. The plates were incubated at 37&#xb0;C for 48&#xa0;h, and then the bacterial growth data were evaluated by measuring the inhibition zones according to literature (<xref ref-type="bibr" rid="B43">Kargar et al., 2021</xref>; <xref ref-type="bibr" rid="B20">Damena et al., 2022a</xref>; <xref ref-type="bibr" rid="B22">Damena et al., 2022b</xref>). All experiments were performed in triplicate, and the mean of the triplicates was reported. The bacterial activities of the synthesized complexes were confirmed by calculating activity index (AI) (<xref ref-type="bibr" rid="B27">El-Gammal et al., 2021</xref>), <xref ref-type="disp-formula" rid="e4">Eq. 4</xref>.<disp-formula id="e4">
<mml:math id="m4">
<mml:mrow>
<mml:mo>%</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>A</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>v</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>y</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>x</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>A</mml:mi>
<mml:mi>I</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>M</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>b</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>z</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>e</mml:mi>
<mml:mtext>&#x2002;</mml:mtext>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>s</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>M</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mtext>&#x2002;</mml:mtext>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>b</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>z</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>e</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>s</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>d</mml:mi>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
<label>(4)</label>
</disp-formula>
</p>
</sec>
<sec id="s2-7">
<title>2.7 Antioxidant activity</title>
<p>The radical scavenging activity study of the ligand and its Zn(II), Cu(II) and Ni(II) complexes were determined using a DPPH assay based on the reported studies (<xref ref-type="bibr" rid="B31">Fetoh et al., 2018</xref>; <xref ref-type="bibr" rid="B49">Kumar et al., 2020</xref>; <xref ref-type="bibr" rid="B73">Sumalatha et al., 2021</xref>). Accordingly, various samples (5, 10, 25, 40, 55, 70, 85, 100, and 115&#xa0;&#x3bc;g/ml) and the assay concentration (40&#xa0;ppm) was prepared, in which 2&#xa0;ml of the assay solution was mixed with 2&#xa0;ml of each of the titled sample compounds. The control was prepared from 2&#xa0;ml of the assay (DPPH) solution and 2&#xa0;ml of solvent (methanol). The vigorously shaken resulting mixtures were put into dark incubator (Labfreez: TSI-200) at 37&#xb0;C for 30&#xa0;min and absorbance was recorded at 517&#xa0;nm in triplicates. The percentage of radical scavenging was determined from average absorbance using <xref ref-type="disp-formula" rid="e5">Eq. 5</xref> based on reported studies (<xref ref-type="bibr" rid="B49">Kumar et al., 2020</xref>; <xref ref-type="bibr" rid="B36">Halevas et al., 2021</xref>):<disp-formula id="e5">
<mml:math id="m5">
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="normal">D</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">P</mml:mi>
<mml:mi mathvariant="normal">H</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">d</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">y</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mo>%</mml:mo>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">A</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
</mml:msub>
</mml:mfrac>
</mml:mrow>
<mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:math>
<label>(5)</label>
</disp-formula>where A<sub>i</sub> and A<sub>S</sub> are the absorbance of the control and sample with control solution, respectively. Finally, the half-maximal inhibitory concentration (IC<sub>50</sub>) was determined from the slope and intercept of the plot of percent radical scavenging activity vs. concentration.</p>
</sec>
<sec id="s2-8">
<title>2.8 Computational methods</title>
<sec id="s2-8-1">
<title>2.8.1 Drug likeness and ADME prediction</title>
<p>Absorption, Distribution, Metabolism, and Excretion (ADME) prediction was performed with SwissADME webtool to understand the safety and efficacy of the metal complexes as drug candidates. The Swiss Institute Bioinformatics (SIB) webtool (SwissADME) was used to convert the two dimensional structure into its simplified molecular input line entry system (SMILES) and then to estimate the <italic>in silico</italic> pharmacokinetic properties (<xref ref-type="bibr" rid="B18">Daina et al., 2017</xref>). In line with the experiment, ciprofloxacin was used as a positive control.</p>
</sec>
<sec id="s2-8-2">
<title>2.8.2 DFT calculations</title>
<p>Geometry optimizations of the ligand (<bold>H</bold>
<sub>
<bold>3</bold>
</sub>
<bold>L</bold>) and its metal complexes (<bold>1</bold>&#x2013;<bold>3</bold>) were performed using the Gaussian 16 program package (<xref ref-type="bibr" rid="B33">Frisch et al., 2016</xref>) and the results were visualized using GaussView 06 and Chemcraft. The density functional theory (DFT) and time dependent DFT (TD-DFT) calculations were performed using the B3LYP hybrid functional (<xref ref-type="bibr" rid="B50">Lee et al., 1988</xref>; <xref ref-type="bibr" rid="B12">Becke, 1993</xref>; <xref ref-type="bibr" rid="B72">Stephens et al., 1994</xref>) together with 6&#x2013;311&#x2b;&#x2b;G (d,p) basis set (<xref ref-type="bibr" rid="B48">Krishnan et al., 1980</xref>) for the light atoms and LanL2DZ basis sets for the metal atoms to account for relativistic effects. Grimme&#x2019;s dispersion correction (<xref ref-type="bibr" rid="B34">Grimme, 2004</xref>) was employed to treat non-bonding interactions during the calculations. Such combination of functional and basis sets has been used in our previous studies (<xref ref-type="bibr" rid="B23">Demissie and Hansen, 2016</xref>; <xref ref-type="bibr" rid="B14">Bitew et al., 2021</xref>; <xref ref-type="bibr" rid="B24">Demissie et al., 2021</xref>; <xref ref-type="bibr" rid="B20">Damena et al., 2022a</xref>; <xref ref-type="bibr" rid="B22">Damena et al., 2022b</xref>). The polarizable continuum model in its integral equation formalism (IEF-PCM) (<xref ref-type="bibr" rid="B75">Tomasi et al., 2005</xref>) was used with methanol solvent to rectify the solvent effects in order to match the experimental conditions. Vibrational frequency calculations were done on the optimized geometries at the same theoretical level, which proved that there were no imaginary vibrational frequencies present and that they were true minima. The wave function distributions of the lowest unoccupied molecular orbital (LUMO), the highest occupied molecular orbital (HOMO), and their Eigen values were estimated. Quantum chemical descriptors such as band gap energy (<italic>E</italic>
<sub>
<italic>g</italic>
</sub> &#x3d; <italic>E</italic>
<sub>LUMO</sub>&#x2013;<italic>E</italic>
<sub>HOMO</sub>), electronegativity (<italic>&#x3c7;</italic> &#x3d; -&#xbd; (<italic>E</italic>
<sub>HOMO</sub> &#x2b; <italic>E</italic>
<sub>LUMO</sub>)), electronic chemical potential (<italic>&#x3bc;</italic> &#x3d; &#xbd; (<italic>E</italic>
<sub>HOMO</sub> &#x2b; <italic>E</italic>
<sub>LUMO</sub>) &#x3d; &#x2212;<italic>&#x3c7;</italic>), global chemical hardness (<italic>&#x3b7;</italic> &#x3d; &#xbd; (<italic>E</italic>
<sub>LUMO</sub>&#x2013;<italic>E</italic>
<sub>HOMO</sub>)), global softness (<italic>&#x3c3;</italic> &#x3d; 1/2<italic>&#x3b7;</italic>), global electrophilicity index (<italic>&#x3c9;</italic> &#x3d; <italic>&#x3bc;</italic>
<sup>
<italic>2</italic>
</sup>
<italic>/2&#x3b7;</italic>), nucleophilicity index (<italic>Nu</italic> &#x3d; 1/<italic>&#x3c9;</italic>)<italic>,</italic> and dipole moment were calculated and analyzed at the same level of theory (<xref ref-type="bibr" rid="B42">Ismael et al., 2020</xref>).</p>
</sec>
<sec id="s2-8-3">
<title>2.8.3 Molecular docking analysis</title>
<p>Using AutoDock 4.2.6 (MGL tools 1.5.7) and a standard methodology, the molecular docking experiments of the free ligand and its metal complexes (<bold>1</bold>&#x2013;<bold>3</bold>) were carried out (<xref ref-type="bibr" rid="B7">Allouche, 2012</xref>) against the active sites of the proteins of <italic>E. coli</italic> DNA gyrase B (PDB ID: 6F86) and <italic>P. aeruginos</italic>a LasR. (PDB ID: 2UV0). With a grid point spacing of 0.375, the grid box was built using 58, 58, and 40 points that pointed in the x, y, and z directions, respectively. The grid box&#x2019;s center was 14.527, 56.689, and 5.122. The Scripps Institute website (<xref ref-type="bibr" rid="B7">Allouche, 2012</xref>) was utilized to download the atom properties for the metal centers (<xref ref-type="bibr" rid="B34">Grimme, 2004</xref>). Using AutoDock scoring routines, hundred alternative conformations for the ligand and its metal complexes were produced and sorted by binding energies. The post-docking evaluations were conducted using PyMOL and AutoDock Tools. The conformations with the lowest free binding energies were chosen to analyze and visualize the interactions between the compounds and the target receptor using PyMOL and Discovery Studio (<xref ref-type="bibr" rid="B67">Rigsby and Parker, 2016</xref>).</p>
</sec>
</sec>
<sec id="s2-9">
<title>2.9 Statistical analysis</title>
<p>The bacterial activities evaluation data with triplicate measurements were determined as mean &#xb1; standard deviation, in which GraphPad Prism version 5.00 was used for the analysis (GraphPad Software, California, United States) (<xref ref-type="bibr" rid="B55">Mogana et al., 2020</xref>). Groups were analyzed for significant differences using analysis of variance (ANOVA) test for correlation with significance (<italic>p</italic> &#x3c; 0.05) (<xref ref-type="sec" rid="s10">Supplementary Table S1</xref>).</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 Molar conductance</title>
<p>The molar conductance of complexes <bold>1</bold> &#x2013; <bold>3</bold> were found to be 5.21, 18.57, and 15.07 &#x3a9;<sup>&#x2212;1</sup>mol<sup>&#x2212;1</sup>cm<sup>2</sup>, respectively (<xref ref-type="sec" rid="s10">Supplementary Table S2</xref>), indicating non-electrolytic nature of the complexes (<xref ref-type="bibr" rid="B16">Chandra and Kumar, 2005</xref>; <xref ref-type="bibr" rid="B42">Ismael et al., 2020</xref>). This is mainly due to the fact that the metal cations receive electrons from the ligand to make a net charge balance of zero. The molar conductance results can also provide information about the proposed structures of the complexes. Hence, the chloride test of Zn(II) complex was performed using a drop of silver nitrate solution. The absence of white precipitate confirmed that chloride ion was coordinated to central metal ion in the inner sphere of the Zn(II) complex, hence the proposed formula of this complex is represented with [Zn(H<sub>2</sub>L)(Cl)] and this in line with reported studies (<xref ref-type="bibr" rid="B42">Ismael et al., 2020</xref>; <xref ref-type="bibr" rid="B22">Damena et al., 2022b</xref>). Although it was discovered that most metal complexes exhibited a non-electrolytic nature, copper (II) and nickel (II) complexes have substantially higher molar conductance than zinc (II) complexes. This could be as a result of the Zn(II) complex&#x2019;s low solubility, which impacts its ion mobility and molar conductance. A previous study suggested that the low molar conductivity of the Zn(II) complex may potentially be due to the absence of anions beyond the coordination sphere (<xref ref-type="bibr" rid="B17">Cond&#xe9; et al., 2022</xref>). Furthermore, this analysis was found to be in line with the DFT optimized geometries (<italic>vide infra</italic>).</p>
</sec>
<sec id="s3-2">
<title>3.2 Formation constants and thermodynamic parameters</title>
<p>The Job&#x2019;s plot for mole fraction of the ligand and the metal ions are presented in <xref ref-type="sec" rid="s10">Supplementary Figure S6</xref>. It was found that the maximum point was recorded at a mole fraction (X) of 0.5, evidencing the synthesized complexes have 1:1 [M:H<sub>3</sub>L] ratio (<xref ref-type="sec" rid="s10">Supplementary Table S3</xref>). Similar results were obtained at temperature elevations up to 40&#xb0;C (<xref ref-type="bibr" rid="B4">Ahmad et al., 2012</xref>; <xref ref-type="bibr" rid="B71">Shalaby and Mohamed, 2020</xref>). The thermodynamic parameters were determined from the plot of lnK vs. 1/T (<xref ref-type="sec" rid="s10">Supplementary Figure S7</xref>). The negative values obtained for the change in Gibbs free energy and enthalpy showed that the complexes are thermally stable up to 40&#xb0;C (<xref ref-type="table" rid="T1">Table 1</xref>). The metal-ligand interactions showed spontaneity and exothermic nature. This is due to larger negative values of Gibbs free energy (&#x394;<italic>G</italic>) and lower negative values of enthalpy change (&#x394;<italic>H</italic>) of the chemical reactions. In other cases, the complex formations are entropically favored due to positive values of change in entropy (&#x394;<italic>S</italic>) (<xref ref-type="bibr" rid="B4">Ahmad et al., 2012</xref>; <xref ref-type="bibr" rid="B71">Shalaby and Mohamed, 2020</xref>; <xref ref-type="bibr" rid="B22">Damena et al., 2022b</xref>). Overall, the formation constants of the complexes remain constant with increase in temperature, inferring that the complexes are stable up to 40&#xb0;C (<xref ref-type="sec" rid="s10">Supplementary Table S3</xref>). This is in line with the thermal analysis study of all the three complexes in which no mass loss was observed up to 100&#xb0;C (<italic>vide infra</italic>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Thermodynamic parameters of the synthesised complexes.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Complexes</th>
<th colspan="4" align="left">
<bold>1</bold>
</th>
<th colspan="4" align="left">
<bold>2</bold>
</th>
<th colspan="4" align="left">
<bold>3</bold>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Temp. (<sup>o</sup>C)</td>
<td align="char" char=".">25</td>
<td align="char" char=".">30</td>
<td align="char" char=".">37</td>
<td align="char" char=".">40</td>
<td align="char" char=".">25</td>
<td align="char" char=".">30</td>
<td align="char" char=".">37</td>
<td align="char" char=".">40</td>
<td align="char" char=".">25</td>
<td align="char" char=".">30</td>
<td align="char" char=".">37</td>
<td align="char" char=".">40</td>
</tr>
<tr>
<td align="left">Lnk</td>
<td align="char" char=".">14.7</td>
<td align="char" char=".">14.7</td>
<td align="char" char=".">14.7</td>
<td align="char" char=".">14.7</td>
<td align="char" char=".">14.9</td>
<td align="char" char=".">14.9</td>
<td align="char" char=".">14.9</td>
<td align="char" char=".">14.9</td>
<td align="char" char=".">12.9</td>
<td align="char" char=".">12.9</td>
<td align="char" char=".">12.9</td>
<td align="char" char=".">12.9</td>
</tr>
<tr>
<td align="left">&#x2212;&#x394;<italic>G</italic> (kJ/mol)</td>
<td align="char" char=".">36.4</td>
<td align="char" char=".">37.0</td>
<td align="char" char=".">37.8</td>
<td align="char" char=".">38.2</td>
<td align="char" char=".">36.9</td>
<td align="char" char=".">37.5</td>
<td align="char" char=".">38.4</td>
<td align="char" char=".">38.8</td>
<td align="char" char=".">31.8</td>
<td align="char" char=".">32.4</td>
<td align="char" char=".">33.1</td>
<td align="char" char=".">33.4</td>
</tr>
<tr>
<td align="left">&#x2212;&#x394;<italic>H</italic> (kJ/mol)</td>
<td colspan="4" align="char" char=".">0.4</td>
<td colspan="4" align="char" char=".">0.8</td>
<td colspan="4" align="char" char=".">0.1</td>
</tr>
<tr>
<td align="left">&#x394;<italic>S</italic> (J/mol)</td>
<td colspan="4" align="char" char=".">122.5</td>
<td colspan="4" align="char" char=".">119.3</td>
<td colspan="4" align="char" char=".">106.7</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-3">
<title>3.3 FTIR analysis</title>
<p>After the successful synthesis of the complexes, the presence and disappearance of characteristic functional groups in the targeted compounds were identified from the FTIR spectral data (<xref ref-type="sec" rid="s10">Supplementary Figures S8, S9</xref>). Accordingly, the spectra showed strong stretching band at 1639&#xa0;cm<sup>&#x2212;1</sup> which was assigned for imine &#x3bd;(C&#x3d;N) group (Im) of the ligand (<xref ref-type="sec" rid="s10">Supplementary Figure S8A</xref>), but in the case of all complexes <bold>1</bold>&#x2013;<bold>3</bold>, this spectral band shifted towards higher frequency range of 1647&#x2013;1688&#xa0;cm<sup>&#x2212;1</sup> (<xref ref-type="sec" rid="s10">Supplementary Table S4</xref>, <xref ref-type="sec" rid="s10">Supplementary Figures S8B, S9C,D</xref>). This confirms the involvement of the donor nitrogen atom of the imine group &#x3bd;(C&#x3d;N) coordinated with the metal ions (<xref ref-type="bibr" rid="B70">Senthil et al., 2012</xref>; <xref ref-type="bibr" rid="B29">El-Sonbati et al., 2019</xref>). Similar to this, the loss of the free ligand&#x2019;s &#x3bd;(O-H) stretching frequency at 3368&#xa0;cm<sup>&#x2212;1</sup> provides proof that the hydroxyl group&#x2019;s oxygen atom participated in the creation of metal-oxygen bonds (<xref ref-type="bibr" rid="B6">Ali et al., 2019</xref>). In addition, the characteristic &#x3bd;(N-H) stretching frequency of the ligand at 3275&#xa0;cm<sup>&#x2212;1</sup> has shifted to 3294, 3168, and 3197&#xa0;cm<sup>&#x2212;1</sup> for Zn(II), Cu(II) and Ni(II) complexes, respectively (<xref ref-type="sec" rid="s10">Supplementary Table S4</xref>). This also indicates the participation of the amine group in the formation of a dative bond during the complex formation process (<xref ref-type="bibr" rid="B6">Ali et al., 2019</xref>; <xref ref-type="bibr" rid="B41">Indira et al., 2019</xref>).</p>
<p>The IR spectral data of Ni(II) and Cu(II) complexes have weak and broad spectral bands of stretching frequencies in the range 3673&#x2013;3373 and 3664&#x2013;3334&#xa0;cm<sup>&#x2212;1</sup>, respectively (<xref ref-type="sec" rid="s10">Supplementary Table S4</xref>). This could be attributed to the vibration of the water molecules that might be present as lattice water and coordination water, respectively. These are newly emerged medium stretching vibration bands at 524&#xa0;cm<sup>&#x2212;1</sup> &#x3bd;(Zn-O) and 460&#xa0;cm<sup>&#x2212;1</sup> &#x3bd;(Zn-N) for the Zn(II) complex; 626&#xa0;cm<sup>&#x2212;1</sup> &#x3bd;(Cu-O) and 474&#xa0;cm<sup>&#x2212;1</sup> &#x3bd;(Cu-N) for the Cu(II) complex; and 534&#xa0;cm<sup>&#x2212;1</sup> &#x3bd;(Ni-O), 462&#xa0;cm<sup>&#x2212;1</sup> &#x3bd;(Ni-N) for the Ni(II) complex. The DFT calculated frequencies are in close agreement with the corresponding experimental results (<xref ref-type="sec" rid="s10">Supplementary Table S4</xref>). The visualization of the DFT calculated frequencies confirmed that all the three metal ions were involved in binding to the ONN donor atoms of the ligand during complex formation (<xref ref-type="bibr" rid="B2">Abd El-Halim et al., 2017</xref>; <xref ref-type="bibr" rid="B6">Ali et al., 2019</xref>; <xref ref-type="bibr" rid="B41">Indira et al., 2019</xref>). The presence of nitrate in both Cu(II) and Ni(II) complexes were confirmed by the strong and broad band IR peaks at 1380 and 1351&#xa0;cm<sup>&#x2212;1</sup>, respectively, in agreement with previously reported studies for related complexes (<xref ref-type="bibr" rid="B6">Ali et al., 2019</xref>; <xref ref-type="bibr" rid="B17">Cond&#xe9; et al., 2022</xref>). Weak O-H bending vibration was observed in the range of 1437&#x2013;1460&#xa0;cm<sup>&#x2212;1</sup> in all the three complexes, confirming the appearance of free bending hydroxyl (O-H) groups. Overall, the close agreement between the DFT calculated IR frequencies and the corresponding experimental results (<xref ref-type="sec" rid="s10">Supplementary Table S4</xref>) further confirmed the analysis.</p>
</sec>
<sec id="s3-4">
<title>3.4 UV-visible spectroscopy</title>
<p>The electronic spectra of the free ligand and the associated Zn(II), Cu(II), and Ni(II) complexes revealed that the ligand absorption bands are primarily caused by &#x3c0;&#x2192;&#x3c0;&#x2a; and n&#x2192;&#x3c0;&#x2a; transitions in UV-Visible spectral data between 200 and 800&#xa0;nm. The peak for Cu(II) and Ni(II) complexes are red shifted, whereas very small blue shift was observed for the Zn(II) complex. The free ligand showed absorption peaks at 231, 258&#xa0;nm (&#x3c0;&#x2192;&#x3c0;&#x2a;) and 300, 383&#xa0;nm (n&#x2192;&#x3c0;&#x2a;) (<xref ref-type="table" rid="T2">Table 2</xref>). The red shifts observed for the Cu(II) and Ni(II) complexes at 406 and 401&#xa0;nm, respectively, are mainly due to ligand-based transitions and ligand to metal charge transfer (LMCT) (<xref ref-type="bibr" rid="B69">Sathisha et al., 2008</xref>; <xref ref-type="bibr" rid="B35">G&#xfc;veli et al., 2014</xref>; <xref ref-type="bibr" rid="B36">Halevas et al., 2021</xref>). This is because the ligand has lone pair electrons and both Cu(II) and Ni(II) complexes have vacant d-orbitals (Dalal M Charge Transfer Spectra; <xref ref-type="bibr" rid="B68">Sallam et al., 2011</xref>). The small band gap energy (3.272&#xa0;eV) of the Cu(II) complex resulted LMCT from the quinoline ring &#x3c0;-orbitals to the metal d-orbitals. Moreover, as it can be seen from the insets of the absorption plots presented in <xref ref-type="fig" rid="F1">Figure 1</xref>, there is a very weak d&#x2192;d transition around 480&#xa0;nm in the case of the Ni(II) complex. Due to the predominance of inter-ligand electron transfers, the Zn(II) complex underwent only minor modification. This might be as a result of Zn(II) having a d<sup>10</sup> electron configuration, which prevents it from taking part in the d&#x2192;d transition (<xref ref-type="bibr" rid="B26">Ekennia et al., 2015</xref>). This is clearly observed from the inset for the experimental absorption plot of the Zn(II) complex. The analysis was supported using the TD-DFT calculated absorption spectra of the complexes. The calculated spectra also showed the same trends and are in very good agreement with the corresponding experimental results (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Electronic spectra of the ligand and the corresponding Zn(II), Cu(II) and Ni(II) complexes.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="left">Absorption (nm)</th>
<th align="left">Transition</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">H<sub>3</sub>L</td>
<td align="left">231, 258, 300, 383</td>
<td align="left">(&#x3c0;&#x2192;&#x3c0;&#x2a;), (n&#x2192;&#x3c0;&#x2a;) and (n&#x2192;&#x3c0;&#x2a;)</td>
</tr>
<tr>
<td align="left">1</td>
<td align="left">231, 258, 300, 380</td>
<td align="left">(&#x3c0;&#x2192;&#x3c0;&#x2a;), (n&#x2192;&#x3c0;&#x2a;) and (n&#x2192;&#x3c0;&#x2a;)</td>
</tr>
<tr>
<td align="left">2</td>
<td align="left">235, 267, 317, 406</td>
<td align="left">(&#x3c0;&#x2192;&#x3c0;&#x2a;), (n&#x2192;&#x3c0;&#x2a;) and LMCT</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left">229, 259, 302, 401</td>
<td align="left">(&#x3c0;&#x2192;&#x3c0;&#x2a;), (n&#x2192;&#x3c0;&#x2a;) and LMCT</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Comparison of the experimental absorption wavelengths with the corresponding TD-B3LYP-GD3/6&#x2013;311&#x2b;&#x2b;G (d,p)/LanL2DZ/IEF-PCM/methanol calculated results of the ligand (<bold>H</bold>
<sub>
<bold>3</bold>
</sub>
<bold>L</bold>), the Zn(II) (<bold>1</bold>), Cu(II) (<bold>2</bold>), and Ni(II) (<bold>3</bold>) complexes. The calculated absorption maxima were red shifted by 20&#xa0;nm for better comparison with the experimental results. Insets are experimental plots for the range between 440 and 540&#xa0;nm.</p>
</caption>
<graphic xlink:href="fchem-10-1053532-g001.tif"/>
</fig>
<p>The characteristics strong bands that appeared between 259&#x2013;383&#xa0;nm in all the three metal complexes were attributed to intra-ligand (C-N or C-O group) electronic transitions, in line with literature (<xref ref-type="bibr" rid="B40">Ilhan et al., 2014</xref>; <xref ref-type="bibr" rid="B52">Mahmoud et al., 2015</xref>; <xref ref-type="bibr" rid="B2">Abd El-Halim et al., 2017</xref>). In addition, the strong absorption bands of all the three metal complexes in the UV region (229&#x2013;258&#xa0;nm) could be assigned to the <italic>N</italic>-quinoline ring (ligand-based &#x3c0;&#x2192;&#x3c0;&#x2a; transitions). The absorption bands above 400&#xa0;nm could be assigned to the LMCT of Cu(II) and Ni(II) complexes (<xref ref-type="table" rid="T2">Table 2</xref>) in agreement with reported studies (<xref ref-type="bibr" rid="B40">Ilhan et al., 2014</xref>; <xref ref-type="bibr" rid="B52">Mahmoud et al., 2015</xref>; <xref ref-type="bibr" rid="B2">Abd El-Halim et al., 2017</xref>). Overall, the analysis of the electronic spectra revealed that d&#x2192;d transition was dominated by LMCT phenomenon and hence the resulted colors of the complexes (<xref ref-type="bibr" rid="B2">Abd El-Halim et al., 2017</xref>). Moreover, the electronic transitions were analyzed based on the frontier molecular orbital (FMO) plots presented in <xref ref-type="fig" rid="F2">Figure 2</xref>. The HOMO and LUMO of the <bold>H</bold>
<sub>
<bold>3</bold>
</sub>
<bold>L</bold> reside on the quinoline ring, confirming the presence of &#x3c0;&#x2192;&#x3c0;&#x2a; electron transition. It is also observed that the electron densities of the HOMO reside on the amine part of the molecule and the LUMO reside on its imine part. This is due to the fact that the amine and imine part of the ligand are in the same plane making it suitable for metal coordination (<xref ref-type="bibr" rid="B38">Hamdani et al., 2020</xref>). The HOMO and LUMO of compounds <bold>1</bold> and <bold>3</bold> are delocalized over the metal centers (Zn and Ni) and the quinoline ring, respectively, inferring the presence of electron transition from metal to the ligand orbital systems for Zn(II) and weak d&#x2192;d transition for Ni(II) complex. Since the d-orbitals of Zn(II) are fully occupied, there is no d&#x2192;d transition in <bold>1</bold> (see inset of <xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The frontier molecular orbitals (HOMO and LUMO) of the ligand and its metal complexes <bold>1</bold>&#x2013;<bold>3</bold>.</p>
</caption>
<graphic xlink:href="fchem-10-1053532-g002.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 Fluorescence study</title>
<p>Fluorescence study was performed at room temperature. The spectra of the ligand (<bold>H</bold>
<sub>
<bold>3</bold>
</sub>
<bold>L</bold>) and its complexes <bold>1</bold>&#x2013;<bold>3</bold> showed emission bands at 526, 608, 471, and 511&#xa0;nm, respectively (<xref ref-type="table" rid="T3">Table 3</xref> and <xref ref-type="sec" rid="s10">Supplementary Figure S10</xref>). Previous reports indicated that the photoluminescence properties of Zn(II) complexes are mainly due to intraligand emissions because of the presence of d<sup>10</sup> electron configuration (<xref ref-type="bibr" rid="B9">Aslkhademi et al., 2019</xref>; <xref ref-type="bibr" rid="B74">Szemik-Hojniak et al., 2020</xref>; <xref ref-type="bibr" rid="B36">Halevas et al., 2021</xref>). In the case of Cu(II) and Ni(II) complexes, the emission intensity enhancement could be mainly due to LMCT (<xref ref-type="bibr" rid="B36">Halevas et al., 2021</xref>; <xref ref-type="bibr" rid="B77">Zheng et al., 2022</xref>). The complexes showed hyperchromic (intense), hypsochromic (blue) shifts, and intense fluorescent bands than the ligand (<xref ref-type="sec" rid="s10">Supplementary Figure S10</xref>). This could be due to an increase in the conformational rigidity of the ligand upon metal coordination. Hence, the metal complexes could potentially be used for photochemical applications (<xref ref-type="bibr" rid="B54">Mandewale et al., 2019</xref>; <xref ref-type="bibr" rid="B74">Szemik-Hojniak et al., 2020</xref>).</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>The emission data of free ligand with its Zn(II), Cu(II) and Ni(II) complexes.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="left">Absorption &#x3bb;<sub>max</sub> (Intensity)</th>
<th align="left">Emission &#x3bb;<sub>max</sub> (Intensity)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">H<sub>3</sub>L</td>
<td align="char" char="(">383 (0.16)</td>
<td align="char" char="(">526 (22.61)</td>
</tr>
<tr>
<td align="left">1</td>
<td align="char" char="(">380 (0.35)</td>
<td align="char" char="(">608 (96.37)</td>
</tr>
<tr>
<td align="left">2</td>
<td align="char" char="(">406 (0.32)</td>
<td align="char" char="(">471 (35.22)</td>
</tr>
<tr>
<td align="left">3</td>
<td align="char" char="(">401 (0.46)</td>
<td align="char" char="(">511 (44.04)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-6">
<title>3.6 Powder X-ray diffraction study</title>
<p>The powder X-ray diffraction (PXRD) patterns of the three synthesized complexes (<bold>1</bold>&#x2013;<bold>3)</bold> have polycrystalline characteristic peaks (<xref ref-type="fig" rid="F3">Figures 3A&#x2013;C</xref>), in line with the previously reported studies (<xref ref-type="bibr" rid="B58">Nagesh et al., 2015</xref>; <xref ref-type="bibr" rid="B56">Morgan et al., 2017</xref>; <xref ref-type="bibr" rid="B62">Ramachandran et al., 2018</xref>; <xref ref-type="bibr" rid="B73">Sumalatha et al., 2021</xref>). The average crystallite size (D) evaluated from the XRD pattern according to Debye&#x2013;Scherrer equation as reported in previous studies (<xref ref-type="bibr" rid="B56">Morgan et al., 2017</xref>; <xref ref-type="bibr" rid="B29">El-Sonbati et al., 2019</xref>; <xref ref-type="bibr" rid="B73">Sumalatha et al., 2021</xref>).<disp-formula id="e6">
<mml:math id="m6">
<mml:mrow>
<mml:mi>D</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>K</mml:mi>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>&#x3b2;</mml:mi>
<mml:mo>&#x2061;</mml:mo>
<mml:mi>cos</mml:mi>
<mml:mo>&#x2061;</mml:mo>
<mml:mi>&#x3b8;</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<label>(6)</label>
</disp-formula>
</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Powder XRD spectral data of: <bold>(A)</bold> Zn(II), <bold>(B)</bold> Cu(II) and <bold>(C)</bold> Ni(II) complexes.</p>
</caption>
<graphic xlink:href="fchem-10-1053532-g003.tif"/>
</fig>
<p>The equation uses the reference peak width at angle &#x3b8;, where <inline-formula id="inf1">
<mml:math id="m7">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> is the wavelength of X-ray radiation (1.5406&#xa0;&#xc5;), <italic>K</italic> is Scherrer constant (0.9) and <inline-formula id="inf2">
<mml:math id="m8">
<mml:mrow>
<mml:mi>&#x3b2;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> is the width at half maximum of the reference diffraction peak measured in degrees (<xref ref-type="bibr" rid="B29">El-Sonbati et al., 2019</xref>). The average crystallite sizes of complexes <bold>1</bold>&#x2013;<bold>3</bold> were found to be 27.86, 33.54 and 37.40&#xa0;nm, respectively, in good agreement with previous reports for related complexes (<xref ref-type="bibr" rid="B56">Morgan et al., 2017</xref>; <xref ref-type="bibr" rid="B62">Ramachandran et al., 2018</xref>). This calculation was done by taking average size of the three major peaks. In addition to this the main reflections were defined based on maxima at 2&#x3b8; that correspond to d values in which the inter-planar spacing (d) was calculated by using Bragg&#x2019;s equation, <inline-formula id="inf3">
<mml:math id="m9">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> n &#x3d; 2dsin&#x3b8;. The calculated inter-planar d-spacing together with relative intensities with respect to most intense peak have been recorded and then h<sup>2</sup>&#x2b;k<sup>2</sup>&#x2b;l<sup>2</sup> values were determined and based on this value, absence of forbidden numbers (7, 15, 23, 71) tell us that cubic or orthorhombic system (translational symmetry) based on the unit cell calculated values. According, the Zn(II) complex showed absence of the forbidden numbers (7, 15, 23, 71) (<xref ref-type="sec" rid="s10">Supplementary Table S5</xref>), indicating that it could be belong to the face centered cubic system with a, b and c values of 7.28, 7.24, and 6.83&#xa0;&#xc5;, respectively (<xref ref-type="bibr" rid="B56">Morgan et al., 2017</xref>). Similarly, the calculated lattice parameters (a, b and c) for the Cu(II) complex were found to be 21.80, 3.86, 8.61, respectively. It was observed that the absence of forbidden numbers (7, 15, 23, 71) (<xref ref-type="sec" rid="s10">Supplementary Table S5</xref>) shows that the Cu(II) complex could belong to orthorhombic systems (<xref ref-type="bibr" rid="B58">Nagesh et al., 2015</xref>; <xref ref-type="bibr" rid="B62">Ramachandran et al., 2018</xref>). Similar calculations were done for the Ni(II) complex and the results showed that the Ni(II) complex could also belong to orthorhombic systems. Hence, the calculated unit cell parameters for Ni(II) complex (a, b and c) were found to be 13.61, 7.47 and 7.02&#xa0;&#xc5;, respectively (<xref ref-type="bibr" rid="B74">Szemik-Hojniak et al., 2020</xref>), which is in agreement with previously reported studies for related complexes (<xref ref-type="bibr" rid="B66">Refat et al., 2013</xref>; <xref ref-type="bibr" rid="B58">Nagesh et al., 2015</xref>; <xref ref-type="bibr" rid="B56">Morgan et al., 2017</xref>; <xref ref-type="bibr" rid="B28">El-Metwaly et al., 2019</xref>; <xref ref-type="bibr" rid="B64">Ramesh et al., 2020</xref>; <xref ref-type="bibr" rid="B3">Abumelha et al., 2021</xref>; <xref ref-type="bibr" rid="B73">Sumalatha et al., 2021</xref>).</p>
</sec>
<sec id="s3-7">
<title>3.7 SEM-EDX study</title>
<p>The compositions of Zn(II), Cu(II) and Ni(II) complexes were analyses from Energy Dispersive X-ray (EDX) analysis, in which the experimental percentage of atoms were found to be very close to the theoretical results (<xref ref-type="bibr" rid="B66">Refat et al., 2013</xref>; <xref ref-type="bibr" rid="B73">Sumalatha et al., 2021</xref>). In the EDX spectrum of [Zn(H<sub>2</sub>L)Cl] complex, five characteristic signals corresponding to atoms C, O, N, Cl and Zn were observed which confirmed the formation of pure CHZnNOCl (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Similarly, the spectrum of [Cu(H<sub>2</sub>L)(H<sub>2</sub>O)(NO<sub>3</sub>)] showed four signals, which correspond to C, O, N, and Cu atoms, indicating pure CHCuNO (<xref ref-type="fig" rid="F4">Figure 4B</xref>). The [Ni(H<sub>2</sub>L)(NO<sub>3</sub>)].2H<sub>2</sub>O complex showed four signals which correspond to C, O, N, and Ni atoms, and indicate the formation of CHNiNO (<xref ref-type="sec" rid="s10">Supplementary Figure S4A</xref>). The free ligand shows three characteristic signals, which clearly confirms the formation of CHNO compound (<xref ref-type="sec" rid="s10">Supplementary Figure S4B</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>EDX of <bold>(A)</bold> Zn(II) and <bold>(B)</bold> Cu(II), and SEM image of <bold>(C)</bold> Zn(II) and <bold>(D)</bold> Cu(II) complexes.</p>
</caption>
<graphic xlink:href="fchem-10-1053532-g004.tif"/>
</fig>
<p>The scanning electron microscopy (SEM) micrographs indicated that the Zn(II) complex shows agglomerates which appear to be stick-like (<xref ref-type="fig" rid="F4">Figure 4C</xref>), whereas the Cu(II) complex shows tiny needles-like agglomerates (<xref ref-type="fig" rid="F4">Figure 4D</xref>), whereas the Ni(II) complex shows flower-like agglomerate structures (<xref ref-type="sec" rid="s10">Supplementary Figure S4C</xref>). From both the SEM and PXRD data, all the three complexes appear to be clear polycrystalline structures in agreement with reported studies (<xref ref-type="bibr" rid="B66">Refat et al., 2013</xref>; <xref ref-type="bibr" rid="B29">El-Sonbati et al., 2019</xref>; <xref ref-type="bibr" rid="B73">Sumalatha et al., 2021</xref>).</p>
</sec>
<sec id="s3-8">
<title>3.8 Mass spectral study</title>
<p>The mass spectrum of complex <bold>1</bold> showed a parent molecular ion peak at <italic>m/z</italic> 357.05 (found 357.98) which corresponds to the formula [C<sub>14</sub>H<sub>16</sub>ClN<sub>3</sub>O<sub>2</sub>Zn] (<xref ref-type="sec" rid="s10">Supplementary Figure S11A</xref>) with a molecular weight of 359.13&#xa0;g/mol. This complex has additional peaks at <italic>m</italic>/<italic>z</italic> 322.07 (8.75%) (found 322.05) and 259.63 (54.75%) (found 260.14), attributed to [C<sub>14</sub>H<sub>16</sub>N<sub>3</sub>O<sub>2</sub>Zn]<sup>&#x2b;</sup> and [C<sub>14</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub>]<sup>&#x2b;</sup> fragments, respectively. Similarly, complex <bold>2</bold> has a parent molecular ion peak at <italic>m/z</italic> 400.08 (found 401.05) which corresponds to the formula [C<sub>14</sub>H<sub>18</sub>CuN<sub>4</sub>O<sub>6</sub>] with a molecular weight of 401.86&#xa0;g/mol (<xref ref-type="sec" rid="s10">Supplementary Figure S11B</xref>). This complex also showed other peaks at <italic>m</italic>/<italic>z</italic> 322 95 (6.70%) (found 322.06), 260.01 (54.75%) (found 260.14) and 226.13 (14.75%) (found 226.13) corresponding to [C<sub>14</sub>H<sub>17</sub>CuN<sub>3</sub>O<sub>2</sub>]<sup>&#x2b;</sup>, [C<sub>14</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub>]<sup>&#x2b;</sup> and [C<sub>14</sub>H<sub>16</sub>N<sub>3</sub>]<sup>&#x2b;</sup> fragments respectively. Finally, complex <bold>3</bold> exhibited a parent molecular ion peak at <italic>m/z</italic> 413.09 (found 414.07) attributed to [C<sub>14</sub>H<sub>20</sub>N<sub>4</sub>NiO<sub>7</sub>] formula with a molecular weight of 415.02&#xa0;g/mol (<xref ref-type="sec" rid="s10">Supplementary Figure S11C</xref>). As usual this complex showed additional peaks at <italic>m</italic>/<italic>z</italic> 351.09 (10.9%) (found 352.08), 315.09 (30.70%) (found 316.06) and 260.33 (29.9%) (found 260.14) corresponding to [C<sub>14</sub>H<sub>20</sub>N<sub>3</sub>NiO<sub>4</sub>]<sup>&#x2b;</sup>, [C<sub>14</sub>H<sub>16</sub>N<sub>3</sub>NiO<sub>2</sub>]<sup>&#x2b;</sup> and [C<sub>14</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub>]<sup>&#x2b;</sup> fragments, respectively. It is important to note that similar observations have been made for other related Ni(II) containing complexes (<xref ref-type="bibr" rid="B15">Bursey, 1974</xref>; <xref ref-type="bibr" rid="B76">Tyagi et al., 2015</xref>; <xref ref-type="bibr" rid="B56">Morgan et al., 2017</xref>; <xref ref-type="bibr" rid="B41">Indira et al., 2019</xref>; <xref ref-type="bibr" rid="B30">El-Sonbati et al., 2020</xref>). Overall, the analysis of the mass spectra and elemental compositions are in good agreement.</p>
</sec>
<sec id="s3-9">
<title>3.9 Thermal gravimetric study</title>
<p>The weight loss of the complexes was measured at temperature ranges 25&#x2013;800&#xb0;C. The results are presented in <xref ref-type="fig" rid="F5">Figures 5A&#x2013;C</xref>, <xref ref-type="sec" rid="s10">Supplementary Figures S12A&#x2013;C</xref> and <xref ref-type="table" rid="T4">Table 4</xref>. The TGA diagram of complex <bold>1</bold> showed three decomposition steps (<xref ref-type="fig" rid="F5">Figure 5A</xref> and <xref ref-type="sec" rid="s10">Supplementary Figure S12A</xref>). The first step of degradation was observed in a temperature range of 255&#x2013;350&#xb0;C (DTA<sub>max</sub> of 325), which indicates a mass loss of 17.80% (calcd. 17.96%) corresponding to the loss of chloroethane (C<sub>2</sub>H<sub>5</sub>Cl) like moiety. The complex was stable up to 200&#xb0;C indicating the absence of both lattice and a water ligands in the specified complex (<xref ref-type="bibr" rid="B58">Nagesh et al., 2015</xref>; <xref ref-type="bibr" rid="B36">Halevas et al., 2021</xref>; <xref ref-type="bibr" rid="B73">Sumalatha et al., 2021</xref>). The second decomposition observed with a weight loss of 21% (calcd. 21.19%) was attributed to the loss of C<sub>6</sub>H<sub>4</sub> fragment of the quinoline ring moiety at 360&#x2013;520&#xb0;C (DTA<sub>max</sub> of 515). The third step of degradation was from mass loss of 29.99% (calcd. 30.38%) which corresponds to the loss of C<sub>5</sub>H<sub>5</sub>N<sub>2</sub>O moiety at a temperature range of 535&#x2013;765&#xb0;C (DTA<sub>max</sub> of 655). The actual weight loss occurred from all these steps are 68.79%, which is in good agreement with the calculated result of 69.53%. Gradual degradation was observed up to 765&#xb0;C and the residue corresponds to zinc oxide (ZnO), 22.52% (calcd. 22.66%), and CHN imine moiety with 7.40% (calcd. 7.53%) of the complex.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>TGA and DTA curves: <bold>(A)</bold> Zn(II), <bold>(B)</bold> Cu(II) and <bold>(C)</bold> Ni(II) complexes.</p>
</caption>
<graphic xlink:href="fchem-10-1053532-g005.tif"/>
</fig>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>TGA and DTA data of Zn(II), Cu(II) and Ni(II) complexes.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left"/>
<th rowspan="2" align="left">Degradation Temp. (<sup>o</sup>C)</th>
<th rowspan="2" align="left">DTA<sub>max</sub> (&#xb0;C)</th>
<th colspan="2" align="left">Weight loss (%)</th>
<th rowspan="2" align="left">Description</th>
</tr>
<tr>
<th align="left">Obsd.</th>
<th align="left">Calcd.</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="3" align="left">
<bold>1</bold>
</td>
<td align="left">255&#x2013;350</td>
<td align="char" char=".">325</td>
<td align="char" char=".">17.80</td>
<td align="char" char=".">17.96</td>
<td align="left">Loss due to chloroethane (C<sub>2</sub>H<sub>5</sub>Cl) like moiety</td>
</tr>
<tr>
<td align="left">360&#x2013;520</td>
<td align="char" char=".">515</td>
<td align="char" char=".">21.00</td>
<td align="char" char=".">21.19</td>
<td align="left">Loss due to C<sub>6</sub>H<sub>4</sub> species of quinoline ring</td>
</tr>
<tr>
<td align="left">535&#x2013;765</td>
<td align="char" char=".">655</td>
<td align="char" char=".">29.99</td>
<td align="char" char=".">30.38</td>
<td align="left">Loss due to C<sub>5</sub>H<sub>5</sub>N<sub>2</sub>O moiety of the quinoline ring</td>
</tr>
<tr>
<td rowspan="3" align="left">
<bold>2</bold>
</td>
<td align="left">100&#x2013;225</td>
<td align="char" char=".">213</td>
<td align="char" char=".">41.69</td>
<td align="char" char=".">41.44</td>
<td align="left">Loss of one water molecule, C<sub>3</sub>H<sub>6</sub>N<sub>2</sub>O and nitrate ion moiety</td>
</tr>
<tr>
<td align="left">240&#x2013;498</td>
<td align="char" char=".">245</td>
<td align="char" char=".">7.26</td>
<td align="char" char=".">7.00</td>
<td align="left">Loss of C<sub>2</sub>H<sub>5</sub> ethane like moiety</td>
</tr>
<tr>
<td align="left">520&#x2013;640</td>
<td align="char" char=".">530</td>
<td align="char" char=".">32.14</td>
<td align="char" char=".">31.89</td>
<td align="left">Loss due to C<sub>9</sub>H<sub>6</sub>N moiety of the quinoline ring</td>
</tr>
<tr>
<td rowspan="4" align="left">
<bold>3</bold>
</td>
<td align="left">100&#x2013;155</td>
<td align="char" char=".">125</td>
<td align="char" char=".">8.65</td>
<td align="char" char=".">8.67</td>
<td align="left">Loss of two lattice water molecule</td>
</tr>
<tr>
<td align="left">220&#x2013;255</td>
<td align="char" char=".">229</td>
<td align="char" char=".">10.23</td>
<td align="char" char=".">10.13</td>
<td align="left">Loss of C<sub>2</sub>H<sub>4</sub>N moiety of imine</td>
</tr>
<tr>
<td align="left">260&#x2013;361</td>
<td align="char" char=".">278</td>
<td align="char" char=".">22.44</td>
<td align="char" char=".">22.41</td>
<td align="left">Loss of CH<sub>3</sub>O &#x2b; NO<sub>3</sub> methanol and nitrate ion moiety</td>
</tr>
<tr>
<td align="left">382&#x2013;610</td>
<td align="char" char=".">508</td>
<td align="char" char=".">28.74</td>
<td align="char" char=".">28.96</td>
<td align="left">Loss due to C<sub>8</sub>H<sub>9</sub>N, moiety of the quinoline ring</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The TGA diagram of complex <bold>2</bold> indicates three decomposition steps (<xref ref-type="fig" rid="F5">Figure 5B</xref> and <xref ref-type="sec" rid="s10">Supplementary Figure S12B</xref>). The first step of degradation was due to mass loss of 41.69% (calcd. 41.69%) corresponding to the elimination of one water molecule, C<sub>3</sub>H<sub>6</sub>N<sub>2</sub>O and nitrate ion moiety at temperature ranges of 100&#x2013;225&#xb0;C (DTA<sub>max</sub> of 213). The second step is due to weight loss of 7.26% (calcd. 7.00%) at temperature ranges 240&#x2013;498&#xb0;C (DTA<sub>max</sub> of 245), which correspond to the elimination of C<sub>2</sub>H<sub>4</sub> ethane like moiety. The final step occurs at temperature ranges of 520&#x2013;640&#xb0;C (DTA<sub>max</sub> of 530) due to the loss of 32.14% (calcd. 31.89%) related to quinoline ring C<sub>9</sub>H<sub>6</sub>N moiety. The leaving residue of the degradation is CuO, which is 18.91% (calcd. 19.80%) of the complex (<xref ref-type="bibr" rid="B66">Refat et al., 2013</xref>; <xref ref-type="bibr" rid="B58">Nagesh et al., 2015</xref>; <xref ref-type="bibr" rid="B6">Ali et al., 2019</xref>). The overall actual weight loss is 81.09%, which is close to the calculated 80.33%.</p>
<p>The thermal decomposition of complex <bold>3</bold> showed four degradation steps (<xref ref-type="fig" rid="F5">Figure 5C</xref> and <xref ref-type="sec" rid="s10">Supplementary Figures S12C</xref>). The first degradation step was due to mass loss of 8.65% (calcd. 8.67%) at temperature ranges of 100&#x2013;155&#xb0;C (DTA<sub>max</sub> of 125) which correspond to the elimination of two lattice water molecules. The second weight loss of 10.23% (calcd. 10.13%) was observed at a temperature ranges of 220&#x2013;255&#xb0;C (DTA<sub>max</sub> of 229), which is attributed to the loss of C<sub>2</sub>H<sub>4</sub>N imine. The third step showed a mass loss of 22.44% (calcd. 22.41%) at temperature ranges of 260&#x2013;361&#xb0;C (DTA<sub>max</sub> of 278) due to loss of (CH<sub>3</sub>O &#x2b; NO<sub>3</sub>) methanol and nitrate ion moiety. The final step of this complex is due to mass loss of 28.74% (calcd. 28.96%) at a temperature ranges of 382&#x2013;610&#xb0;C (DTA<sub>max</sub> of 508), which corresponds to the loss of quinoline ring moiety. The leaving residues of nickel oxide (NiO), representing 29.24% (calcd. 27.22%) of the complex. The actual mass loss from all these steps is 70.06%, which is in very good agreement with the calculated result (69.91%).</p>
<p>Overall, the percentage content of elements obtained from both the elemental and TGA analyses are in very good agreement for all the three complexes. The general degradation pattern of the Cu(II) and Zn(II) complexes arise in three stages, while that of Ni(II) complex occurred in four stages. The thermogram of complexes <bold>1</bold>&#x2013;<bold>3</bold> beyond 765, 640 and 610&#xb0;C, respectively, showed a straight line, indicating the formation of metal oxides (<xref ref-type="bibr" rid="B8">Ambala and Lincoln, 2020</xref>). All the complexes were stable up to 100&#xb0;C without any weight loss, in line with the spectroscopically evaluated stability constants which do not change up to 40&#xb0;C (<xref ref-type="sec" rid="s10">Supplementary Table S5</xref>). This is a good indication that the complexes could be potentially important for biological applications. Overall, the results are in very good agreement with the formulae proposed from the analytical data (<xref ref-type="scheme" rid="sch1">Scheme 1</xref>).</p>
</sec>
<sec id="s3-10">
<title>3.10 Biological applications</title>
<sec id="s3-10-1">
<title>3.10.1 Antibacterial activity</title>
<p>The results from <italic>in vitro</italic> antibacterial activity study of the ligand and complexes <bold>1</bold>&#x2013;<bold>3</bold> are presented in <xref ref-type="table" rid="T5">Table 5</xref> and <xref ref-type="fig" rid="F6">Figure 6</xref>. The mean inhibition zone (MIZ) of the compounds showed potential antibacterial activity compared to ciprofloxacin. The ligand used in this study was prepared based on the quinoline scaffold. Thus, it is natural to expect similar mode of action of the complexes synthesized from this ligand with that of ciprofloxacin. The analysis of the antibacterial data revealed that all the three transition metal complexes exhibited activity ranging from low to high MIZ with 8 &#xb1; 0.13&#xa0;mm at 150&#xa0;<italic>&#x3bc;</italic>g/ml for the Ni(II) complex against <italic>E. coli</italic>, and 20.65 &#xb1; 0.18&#xa0;mm at 300&#xa0;<italic>&#x3bc;</italic>g/ml for the Cu(II) complex against <italic>P. aeruginosa</italic>. All the three complexes exhibited good activities against <italic>P. aeruginosa</italic> (18.85 &#xb1; 0.34, 20.65 &#xb1; 0.18, and 15.64 &#xb1; 0.22&#xa0;mm diameter at concentration of 300&#xa0;<italic>&#x3bc;</italic>g/ml, respectively) compared to ciprofloxacin with MIZ of 22.98 &#xb1; 0.08&#xa0;mm diameter. These results are in close agreement with previously reported results for related complexes (<xref ref-type="bibr" rid="B41">Indira et al., 2019</xref>; <xref ref-type="bibr" rid="B43">Kargar et al., 2021</xref>; <xref ref-type="bibr" rid="B73">Sumalatha et al., 2021</xref>).</p>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>Mean inhibition zone of bacterial growth in mm (mean &#xb1; SD).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left"/>
<th rowspan="2" align="left">Conc. (&#xb5;g/ml)</th>
<th colspan="5" align="left">Compounds</th>
</tr>
<tr>
<th align="left">
<bold>1</bold>
</th>
<th align="left">
<bold>2</bold>
</th>
<th align="left">
<bold>3</bold>
</th>
<th align="left">
<bold>H</bold>
<sub>
<bold>3</bold>
</sub>
<bold>L</bold>
</th>
<th align="left">Ciprofloxacin</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="2" align="left">
<italic>E. coli</italic>
</td>
<td align="char" char=".">150</td>
<td align="left">10.62 &#xb1; 0.36</td>
<td align="left">12.69 &#xb1; 0.23</td>
<td align="left">8.00 &#xb1; 0.13</td>
<td align="left">6.22 &#xb1; 0.14</td>
<td align="left">21.50 &#xb1; 0.28</td>
</tr>
<tr>
<td align="char" char=".">300</td>
<td align="left">12.00 &#xb1; 0.66</td>
<td align="left">13.57 &#xb1; 0.29</td>
<td align="left">9.00 &#xb1; 0.64</td>
<td align="left">6.50 &#xb1; 0.36</td>
<td align="left">22.00 &#xb1; 0.50</td>
</tr>
<tr>
<td rowspan="2" align="left">
<italic>P. aeruginosa</italic>
</td>
<td align="char" char=".">150</td>
<td align="left">16.69 &#xb1; 0.18</td>
<td align="left">18.51 &#xb1; 0.37</td>
<td align="left">15.07 &#xb1; 0.01</td>
<td align="left">6.00 &#xb1; 0.25</td>
<td align="left">20.52 &#xb1; 0.40</td>
</tr>
<tr>
<td align="char" char=".">300</td>
<td align="left">18.85 &#xb1; 0.34</td>
<td align="left">20.65 &#xb1; 0.18</td>
<td align="left">15.64 &#xb1; 0.22</td>
<td align="left">6.24 &#xb1; 0.39</td>
<td align="left">22.98 &#xb1; 0.08</td>
</tr>
<tr>
<td rowspan="2" align="left">
<italic>S. aureus</italic>
</td>
<td align="char" char=".">150</td>
<td align="left">11.30 &#xb1; 0.17</td>
<td align="left">17.10 &#xb1; 0.10</td>
<td align="left">12.50 &#xb1; 0.31</td>
<td align="left">0.00 &#xb1; 0.00</td>
<td align="left">19.00 &#xb1; 0.92</td>
</tr>
<tr>
<td align="char" char=".">300</td>
<td align="left">13.22 &#xb1; 0.74</td>
<td align="left">17.99 &#xb1; 0.03</td>
<td align="left">13.24 &#xb1; 0.21</td>
<td align="left">0.00 &#xb1; 0.00</td>
<td align="left">20.80 &#xb1; 0.37</td>
</tr>
<tr>
<td rowspan="2" align="left">
<italic>S. pyogenes</italic>
</td>
<td align="char" char=".">150</td>
<td align="left">10.22 &#xb1; 0.89</td>
<td align="left">8.50 &#xb1; 0.28</td>
<td align="left">0.00 &#xb1; 0.00</td>
<td align="left">6.20 &#xb1; 0.15</td>
<td align="left">15.90 &#xb1; 0.55</td>
</tr>
<tr>
<td align="char" char=".">300</td>
<td align="left">12.22 &#xb1; 0.66</td>
<td align="left">10.64 &#xb1; 0.70</td>
<td align="left">0.00 &#xb1; 0.00</td>
<td align="left">7.00 &#xb1; 0.11</td>
<td align="left">17.00 &#xb1; 0.94</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Antibacterial activity of the ligand and its Zn(II), Cu(II) and Ni(II) complexes at 150&#xa0;&#x3bc;g/ml. Error bars indicate standard deviations.</p>
</caption>
<graphic xlink:href="fchem-10-1053532-g006.tif"/>
</fig>
<p>Complexes <bold>1</bold> and <bold>2</bold> have medium to high antibacterial activities with MIZ from 10.62 &#xb1; 0.36 to 20.65 &#xb1; 0.18&#xa0;mm at both 150 and 300&#xa0;<italic>&#x3bc;</italic>g/ml concentrations of the samples against all the four bacterial strains. However, complex <bold>3</bold> has low to medium MIZ (8 &#xb1; 0.13 to 15.64 &#xb1; 0.22&#xa0;mm diameter) at both concentrations against <italic>E. coli</italic>, <italic>P. aeruginosa</italic> and <italic>S. aurous</italic>, but has no antibacterial activity against <italic>S. pyogenes</italic>. Due to the metal&#x2019;s chelation with the ligand, which encouraged the complexes&#x2019; capacity to enter the bacterial strains&#x2019; cell membranes, all of the complexes had more antibacterial activity than the precursor ligand (<xref ref-type="bibr" rid="B2">Abd El-Halim et al., 2017</xref>; <xref ref-type="bibr" rid="B41">Indira et al., 2019</xref>; <xref ref-type="bibr" rid="B73">Sumalatha et al., 2021</xref>). From the % activity index data, it can be concluded that Cu(II) complex has higher percent activity indexes (62, 90%) than Zn(II) (54, 82%) and Ni(II) (41, 68%) complexes against both <italic>E. coli</italic> and <italic>P. aeruginosa,</italic> respectively. This is may be due to Cu(II) ion is a borderline Lewis acid and easily bind with similar biochemical such as protein and enzyme by &#x201c;hard soft acid-base (HSAB)&#x201d; Principle hence copper complexes showed good binding activity with G. negative (<italic>Pseudomonas aeruginosa)</italic> bacterial strain due to H- bonding interaction with amino acid like arginine having both acid and base end (<xref ref-type="table" rid="T5">Table 5</xref>). In addition to this, copper (II) coordination compounds can be highly effective in treating microbial infections due to the redox activity of copper ions which interacted with the bacterial chromosome, leading to a decrease in bacterial reproduction (<xref ref-type="bibr" rid="B47">Krasnovskaya et al., 2020</xref>).</p>
</sec>
<sec id="s3-10-2">
<title>3.10.2 Antioxidant analysis</title>
<p>The antioxidant activities of the ligand and its complexes <bold>1</bold>&#x2013;<bold>3</bold> were compared with ascorbic acid as a positive reference (<xref ref-type="fig" rid="F7">Figure 7</xref>). The complexes showed higher antioxidant activities than the corresponding ligand (<xref ref-type="sec" rid="s10">Supplementary Figure S18A</xref> and <xref ref-type="sec" rid="s10">Supplementary Table S7</xref>). This is anticipated to be due to synergetic effects (<xref ref-type="bibr" rid="B27">El-Gammal et al., 2021</xref>; <xref ref-type="bibr" rid="B73">Sumalatha et al., 2021</xref>), and hence the complexes can potentially be used as radical scavengers. The order follows ascorbic acid &#x3e; <bold>2</bold> &#x3e; <bold>1</bold> &#x3e; <bold>3</bold> &#x3e; <bold>H</bold>
<sub>
<bold>3</bold>
</sub>
<bold>L</bold>. These results are also in line with the IC<sub>50</sub> values of 10.46, 8.62, 27.56 and 35.36&#xa0;&#x3bc;g/ml for complexes <bold>1</bold>&#x2013;<bold>3</bold> and the ligand, respectively. From the IC<sub>50</sub> values, complexes <bold>1</bold> and <bold>2</bold> have better antioxidant activities, (<xref ref-type="sec" rid="s10">Supplementary Figure S18B</xref> and <xref ref-type="sec" rid="s10">Supplementary Table S7</xref>). This is may be due to high redox activity, of zinc and copper complex, hence both are important for the formation and functioning of several enzymes and proteins, such as cytochrome C oxidase and Cu/Zn superoxide dismutase, which are involved in the processes of respiration, energy metabolism, and DNA synthesis (<xref ref-type="bibr" rid="B47">Krasnovskaya et al., 2020</xref>; <xref ref-type="bibr" rid="B49">Kumar et al., 2020</xref>; <xref ref-type="bibr" rid="B20">Damena et al., 2022a</xref>), because copper is involved in catalysis (electron transfer), while zinc plays a structural role in these proteins. In addition to, this high activity was probably due to the presence of the OH group in addition to oxidation potential of the metal ions and the decrease of the antioxidant activity of the ligands is indicated that the terminal N-substitution in the ligands does not have any appreciable influence much on the antioxidant properties in agreement with previous reported studies (<xref ref-type="bibr" rid="B63">Ramachandran et al., 2013</xref>; <xref ref-type="bibr" rid="B31">Fetoh et al., 2018</xref>; <xref ref-type="bibr" rid="B1">Abane-Merzouk et al., 2019</xref>; <xref ref-type="bibr" rid="B13">Belkhir-Talbi et al., 2021</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Comparison of absorbance of the control, the reference and the complexes.</p>
</caption>
<graphic xlink:href="fchem-10-1053532-g007.tif"/>
</fig>
</sec>
</sec>
<sec id="s3-11">
<title>3.11 Computational analysis of the compounds</title>
<sec id="s3-11-1">
<title>3.11.1 Drug-likeness and ADME predictions</title>
<p>The physicochemical, ADME properties and drug likeness of the ligand and metal complexes are presented in <xref ref-type="sec" rid="s10">Supplementary Table S8A</xref>. The compounds have molecular weights ranging from 259.30 to 400.85&#xa0;g/mol. The iLogP value of the ligand was found to be 2.22 and that of all the metal complexes showed similar iLogP value of zero compared to ciprofloxacin (2.24). The low value of iLogP for the metal complexes indicates good water solubility of the metal complexes relative to the ligand and the control (<xref ref-type="bibr" rid="B11">Balajee et al., 2016</xref>). This is in line with the experimental solubility test results.</p>
<p>The number of hydrogen bond donors of all the compounds range from 2 to 3 (&#x2264;5), whereas the number of hydrogen bond acceptors range from 4 to 8 (&#x2264;10). The predicted physicochemical properties for drug likeness screening showed that all the synthesized compounds fulfil drug-like molecular nature (<xref ref-type="bibr" rid="B51">Lipinski et al., 2012</xref>). Moreover, the topological polar surface area (TPSA) ranges from 56 to 142&#xa0;&#xc5;<sup>2</sup> for the synthesized compounds. The smaller TPSA value predicted for the Zn(II) complex (57&#xa0;&#xc5;<sup>2</sup>) relative to the ligand&#x2019;s TPSA value (77.74&#xa0;&#xc5;<sup>2</sup>) is due to the lipophilicity enhancement of the ligand upon coordination with the Zn(II) ion. This phenomenon was also observed in the boiled egg model (<xref ref-type="sec" rid="s10">Supplementary Figure S13</xref>) of the synthesized compounds, in which the compounds follow the lipophilicity order of <bold>1</bold> &#x3e; <bold>H</bold>
<sub>
<bold>3</bold>
</sub>
<bold>L</bold> &#x3e; <bold>3</bold> &#x3e; <bold>2</bold>. It has been reported that compounds with TPSA of 140&#xa0;&#xc5;<sup>2</sup> and above would be poorly absorbed (&#x3c;10% fractional absorption) and those with a TPSA 60&#xa0;&#xc5;<sup>2</sup> would be well absorbed (&#x3e;90%) (<xref ref-type="bibr" rid="B51">Lipinski et al., 2012</xref>; <xref ref-type="bibr" rid="B13">Belkhir-Talbi et al., 2021</xref>). From the TPSA data of the synthesized compounds, it is possible to deduce that the ligand and its metal complexes have very good intestinal absorption (<xref ref-type="bibr" rid="B51">Lipinski et al., 2012</xref>; <xref ref-type="bibr" rid="B18">Daina et al., 2017</xref>)<sup>.</sup>
</p>
<p>Skin permeability (logKp) value of the free ligand and its metal complexes were found within the range of &#x2212;7.10 to &#x2212;7.53&#xa0;cms<sup>&#x2212;1</sup> (<xref ref-type="sec" rid="s10">Supplementary Table S8B</xref>), deducing that all compounds have low skin permeability (<xref ref-type="bibr" rid="B51">Lipinski et al., 2012</xref>; <xref ref-type="bibr" rid="B18">Daina et al., 2017</xref>). Similarly, the synthesized compounds were predicted as a substrate of P-glycoprotein (P-gp) which is a transporter and biological barrier and responsible for the ADME of drugs (<xref ref-type="bibr" rid="B18">Daina et al., 2017</xref>)<sup>.</sup> This inferred that the compounds have no tendency to interact with other drugs fingered by the transporter and hence no drug-drug interactions. The inhibition of CYPs leads to toxicity end points (<xref ref-type="bibr" rid="B45">Khojasteh et al., 2011</xref>). The high gastrointestinal absorption (GI) together with their fewer tendencies to inhibit cytochrome P450 enzyme family of the liver (CYPs) indicated that the compounds are theoretically non-toxic.</p>
</sec>
<sec id="s3-11-2">
<title>3.11.2 Quantum chemical analysis</title>
<p>The DFT calculated quantum mechanical descriptors are presented in <xref ref-type="table" rid="T6">Table 6</xref>. The band gap energy (<italic>E</italic>
<sub>g</sub>) is correlated with various biological aspects like antibacterial, antioxidant and DNA binding activities (<xref ref-type="bibr" rid="B6">Ali et al., 2019</xref>; <xref ref-type="bibr" rid="B42">Ismael et al., 2020</xref>). It is also an important stability descriptor (<xref ref-type="bibr" rid="B11">Balajee et al., 2016</xref>). A large band gap energy is associated with stable systems, whereas small band gap energy is associated with little stable systems making more reactive compounds (<xref ref-type="bibr" rid="B11">Balajee et al., 2016</xref>). The band gap energies of the compounds were found to be 3.834, 4.002, 3.272 and 3.669&#xa0;eV, respectively for <bold>H</bold>
<sub>
<bold>3</bold>
</sub>
<bold>L</bold>, <bold>1</bold>, <bold>2</bold>, and <bold>3</bold>. The calculated band gap energies for compounds <bold>2</bold> and <bold>3</bold> were found to be less by 0.562 and 0.165 eV, respectively, relative to the ligand (<xref ref-type="table" rid="T6">Table 6</xref>). A decrease in the band gap energy upon coordination may be associated with the presence of LMCT (<xref ref-type="bibr" rid="B42">Ismael et al., 2020</xref>). The band gap energy of complex <bold>1</bold> (4.002&#xa0;eV) was higher than that of the ligand (3.834&#xa0;eV) by 0.168&#xa0;eV, inferring the presence of electron transfer from the HOMO of the metal center to the LUMO of the quinoline part of the ligand (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<table-wrap id="T6" position="float">
<label>TABLE 6</label>
<caption>
<p>Quantum chemical descriptors of the ligand and its metal complexes.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Cpds</th>
<th align="left">
<italic>E</italic>
<sub>HOMO</sub>
</th>
<th align="left">
<italic>E</italic>
<sub>LUMO</sub>
</th>
<th align="left">
<italic>E</italic>
<sub>g</sub> (eV)</th>
<th align="left">
<italic>&#xb5;</italic>
</th>
<th align="left">
<italic>&#x19e;</italic>
</th>
<th align="left">&#x3c3;</th>
<th align="left">&#x03C9;</th>
<th align="left">Nu</th>
<th align="left">Dipole moment</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">H<sub>3</sub>L</td>
<td align="char" char=".">&#x2212;5.960</td>
<td align="char" char=".">&#x2212;2.126</td>
<td align="char" char=".">3.834</td>
<td align="char" char=".">&#x2212;4.043</td>
<td align="char" char=".">1.917</td>
<td align="char" char=".">0.261</td>
<td align="char" char=".">4.264</td>
<td align="char" char=".">0.235</td>
<td align="char" char=".">5.864</td>
</tr>
<tr>
<td align="left">1</td>
<td align="char" char=".">&#x2212;6.364</td>
<td align="char" char=".">&#x2212;2.362</td>
<td align="char" char=".">4.002</td>
<td align="char" char=".">&#x2212;4.363</td>
<td align="char" char=".">2.001</td>
<td align="char" char=".">0.250</td>
<td align="char" char=".">4.756</td>
<td align="char" char=".">0.210</td>
<td align="char" char=".">14.413</td>
</tr>
<tr>
<td align="left">2</td>
<td align="char" char=".">&#x2212;6.571</td>
<td align="char" char=".">&#x2212;3.299</td>
<td align="char" char=".">3.272</td>
<td align="char" char=".">&#x2212;4.935</td>
<td align="char" char=".">1.636</td>
<td align="char" char=".">0.306</td>
<td align="char" char=".">7.445</td>
<td align="char" char=".">0.134</td>
<td align="char" char=".">19.043</td>
</tr>
<tr>
<td align="left">3</td>
<td align="char" char=".">&#x2212;6.303</td>
<td align="char" char=".">&#x2212;2.634</td>
<td align="char" char=".">3.669</td>
<td align="char" char=".">&#x2212;4.468</td>
<td align="char" char=".">1.834</td>
<td align="char" char=".">0.273</td>
<td align="char" char=".">5.441</td>
<td align="char" char=".">0.184</td>
<td align="char" char=".">20.777</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Cpds, compounds; E<sub>H</sub>, HOMO energy; E<sub>L</sub>, LUMO energy and Eg &#x003D; HOMO-LUMO band gap energy.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>According to the HSAB principle, soft acids react with soft bases, whereas hard acids react with hard bases (<xref ref-type="bibr" rid="B60">Pearson, 1968</xref>; <xref ref-type="bibr" rid="B42">Ismael et al., 2020</xref>). Biological molecules such as DNA, proteins, and enzymes are categorized as soft. Hence, the biological activity of a compound increases with increasing softness and decreasing hardness (<xref ref-type="bibr" rid="B60">Pearson, 1968</xref>; <xref ref-type="bibr" rid="B42">Ismael et al., 2020</xref>). The order of chemical hardness (&#x273;) was found to be <bold>1</bold> &#x3e; <bold>H</bold>
<sub>
<bold>3</bold>
</sub>
<bold>L</bold> &#x3e; <bold>3</bold> &#x3e; <bold>2</bold>, suggesting that complex <bold>1</bold> is more stable. This nicely agrees with the TGA analysis (<xref ref-type="table" rid="T3">Table 3</xref>). Chemical potential (&#xb5;) measures the tendency of an electron to escape from equilibrium, and it has been reported that the chemical reactivity of a compound increases with decreasing chemical potential (<xref ref-type="bibr" rid="B42">Ismael et al., 2020</xref>; <xref ref-type="bibr" rid="B20">Damena et al., 2022a</xref>; <xref ref-type="bibr" rid="B22">Damena et al., 2022b</xref>). Chemical potential (&#xb5;) is also directly proportional with the Gibbs free energy and related to spontaneity (<xref ref-type="table" rid="T1">Table 1</xref>). Therefore, the order of chemical reactivity for the synthesized compounds is <bold>2</bold> &#x3e; <bold>3</bold> &#x3e; <bold>1</bold> &#x3e; H<sub>3</sub>
<bold>L</bold> (<xref ref-type="table" rid="T6">Table 6</xref>), in which compound <bold>2</bold> is higher than that of compounds <bold>3</bold>, <bold>1</bold> and <bold>H</bold>
<sub>
<bold>3</bold>
</sub>
<bold>L</bold> by 0.467, 0.572 and 0.892&#xa0;eV, respectively. This indicates that compound <bold>2</bold> is more reactive and also nicely agrees with the experimental and molecular docking studies. The dipole moment (in Debye) of the ligand showed large enhancement upon coordination to metal ions (<xref ref-type="table" rid="T6">Table 6</xref>). This general increase in the dipole moment of the ligand upon coordination is subsequently observed in the antioxidant and antibacterial activity of the synthesized complexes (<italic>vide supra</italic>).</p>
</sec>
<sec id="s3-11-3">
<title>3.11.3 Molecular docking analysis</title>
<p>We studied the molecular interaction between the synthesized ligand and its metal complexes against the proteins of <italic>E. coli</italic> DNA gyrase B (PDB ID 6F86) (<xref ref-type="sec" rid="s10">Supplementary Figure S14</xref>) and <italic>P. aeruginosa</italic> LasR (PDB ID: 2UV0) (<xref ref-type="sec" rid="s10">Supplementary Figures S15, S16</xref> and <xref ref-type="fig" rid="F8">Figure 8</xref>) to understand the mechanism of action. The targeted ligand and its metal complexes interacted with the key amino acids of <italic>E. coli</italic> DNA gyrase B by forming hydrogen bond with Asp-73, Gly-77, Thr-165, and hydrophobic interaction with Ile-78, Ile-94, Glu-50, and Pro-79 within the active sites (<xref ref-type="sec" rid="s10">Supplementary Figure S14</xref>). The results clearly showed that the free hydroxyl chain in the complexes interacted with the amino acids within the active sites of the protein. Among all the reported docking scores, Cu(II) complex showed better docking score, in which the overall <italic>in silico</italic> analysis results revealed the ranking of the complexes as antibacterial agents with the order Cu(II) &#x3e; Zn(II) &#x3e; Ni(II) complexes against the <italic>E. coli</italic> DNA gyrase B (<xref ref-type="sec" rid="s10">Supplementary Table S9</xref>). This is also in a good agreement with the experimental <italic>in vitro</italic> antibacterial activity results (<xref ref-type="table" rid="T5">Table 5</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>The binding interactions of (<bold>(A)</bold>: 3D and <bold>(B)</bold>: 2D presentations) of complexes <bold>2</bold> and <bold>3</bold> against <italic>P. aeruginosa</italic> LasR.DNA (PDB: 2UV0).</p>
</caption>
<graphic xlink:href="fchem-10-1053532-g008.tif"/>
</fig>
<p>We also looked at how the <italic>P. aeruginosa</italic> LasR DNA protein interacted with the synthetic metal complexes to acquire further knowledge. The 2D and 3D representation of the interactions for the compounds and ciprofloxacin are presented in <xref ref-type="fig" rid="F8">Figure 8</xref> and <xref ref-type="sec" rid="s10">Supplementary Figures S15, S16</xref>, whereas the binding scores and the residual protein-ligand interactions are summarized in <xref ref-type="sec" rid="s10">Supplementary Table S10</xref>. The metal complexes have shown significant interactions within the active sites of the LasR.DNA protein with the key amino acids, for instance Tyr-47, Trp-60, Asp-73, Tyr-64, Leu-36, Trp-88, Arg-61, Thr-75, Cys-79, and Ala-127 (<xref ref-type="bibr" rid="B39">Hussein and Elkhair, 2021</xref>). All the investigated compounds showed moderate to equivalent binding scores compared to the clinical drug ciprofloxacin (<xref ref-type="sec" rid="s10">Supplementary Table S10</xref>). The overall <italic>in silico</italic> docking analysis indicated that the Cu(II) complex interacted with the LasR.DNA residues with a binding energy of &#x2212;8.2&#xa0;kcal/mol. This result is comparable with the binding energy of ciprofloxacin (&#x2212;8.00&#xa0;kcal/mol). Similar docking activity trends were observed for both <italic>E. coli</italic> DNA gyrase B (<xref ref-type="sec" rid="s10">Supplementary Figure S14</xref>) and <italic>P. aeruginosa</italic> LasR (<xref ref-type="sec" rid="s10">Supplementary Figures S15, S16</xref>), all in good agreement with the <italic>in vitro</italic> antibacterial activity results.</p>
</sec>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>Three new quinoline-based transition metal complexes were synthesized and characterized using PXRD, SEM-EDX, MS, <sup>1</sup>HNMR, <sup>13</sup>CNMR, UV-visible spectroscopy, fluorescence spectroscopy, FT-IR, TGA and molar conductance techniques. Density functional theory calculations were used to assist the interpretation of the results. The formation constants of the complexes were found to be in very good agreements with the corresponding thermal stability analysis. All the complexes showed better antibacterial activities than the precursor ligand, particularly the Cu(II) complex showed relatively highest antibacterial activity with mean inhibition zone of 20.65 &#xb1; 0.18&#xa0;mm. Moreover, the Zn(II) and Cu(II) complexes showed better antioxidant activities. The calculated results also showed that none of the target complexed violate Lipinski&#x2019;s rule of five. The <italic>in silico</italic> drug likeness and molecular docking results agree very well with the corresponding experimental results. The high antibacterial activity of copper complex against Gram-negative bacteria makes the complexes potential alternative drug for treating diseases caused by Gram-negative bacteria after passing cytotoxicity testing. Overall, there is a chance that the ligand and its metal complexes could be further improved for use as medicinal compounds because they have consequently shown promising antioxidant and antibacterial characteristics.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>Experimental: TdD and DZ. Methodology and data analysis: TdD, DZ, MBA, TgD, TBD, and RE. Original draft writing: TdD, TgD, and TBD. Review and editing: TdD, TBD, DZ, MBA, and TgD.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>Computational resources were supplied by the project &#x201c;e-Infrastruktura CZ&#x201d; (e-INFRA CZ ID: 90140) supported by the Ministry of Education, Youth and Sports of the Czech Republic.</p>
</sec>
<ack>
<p>The authors would like to acknowledge Adama Science and Technology University, Wachemo University and University of Botswana for the research facilities. We also would like to thank the three referees for their very constructive suggestions and comments.</p>
</ack>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2022.1053532/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchem.2022.1053532/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abane-Merzouk</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Adkhis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Terrachet-Bouaziz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Makhloufi-Chebli</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Synthesis, DFT/TD-DFT theoretical studies, experimental characterization, electrochemical and antioxidant activity of Fe(III) complexes of bis (dimethylglyoximato) guanine</article-title>. <source>J. Mol. Struct.</source> <volume>1186</volume>, <fpage>413</fpage>&#x2013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2019.02.108</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abd El-Halim</surname>
<given-names>H. F.</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>G. G.</given-names>
</name>
<name>
<surname>Khalil</surname>
<given-names>E. A. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Synthesis, spectral, thermal and biological studies of mixed ligand complexes with newly prepared Schiff base and 1, 10-phenanthroline ligands</article-title>. <source>J. Mol. Struct.</source> <volume>1146</volume>, <fpage>153</fpage>&#x2013;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2017.05.092</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abumelha</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Alkhatib</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Alzahrani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Abualnaja</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alsaigh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alfaifi</surname>
<given-names>M. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Synthesis and characterization for pharmaceutical models from Co(II), Ni(II) and Cu(II)-thiophene complexes; apoptosis, various theoretical studies and pharmacophore modeling</article-title>. <source>J. Mol. Liq.</source> <volume>328</volume>, <fpage>115483</fpage>&#x2013;<lpage>115512</lpage>. <pub-id pub-id-type="doi">10.1016/j.molliq.2021.115483</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hamid</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hamid</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sarwar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Memon</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Ghangro</surname>
<given-names>A. B.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Spectrophotometric study of stability constants of cimetidine &#x2013; Ni ( II ) complex at different temperatures</article-title>. <source>Arab. J. Chem.</source> <volume>5</volume>, <fpage>309</fpage>&#x2013;<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1016/j.arabjc.2010.09.009</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alem</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Damena</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Desalegn</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Koobotse</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eswaramoorthy</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ngwira</surname>
<given-names>K. J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Cytotoxic mixed-ligand complexes of Cu ( II ): A combined experimental and computational study</article-title>. <source>Front. Chem.</source> <volume>10</volume>, <fpage>1028957</fpage>&#x2013;<lpage>1029014</lpage>. <pub-id pub-id-type="doi">10.3389/fchem.2022.1028957</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>I. A. I.</given-names>
</name>
<name>
<surname>El-Sakka</surname>
<given-names>S. S. A.</given-names>
</name>
<name>
<surname>Soliman</surname>
<given-names>M. H. A.</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>O. E. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>
<italic>In silico</italic>, <italic>in Vitro</italic> and docking applications for some novel complexes derived from new quinoline derivatives</article-title>. <source>J. Mol. Struct.</source> <volume>1196</volume>, <fpage>8</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2019.06.053</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allouche</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Gabedit-A graphical user interface for computational chemistry softwares</article-title>. <source>J. Comput. Chem.</source> <volume>32</volume>, <fpage>174</fpage>&#x2013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21600</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ambala</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lincoln</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Synthesis, characterization, antimicrobial activity and DNA cleavage study of (E)-2-(((2-(P-Tolyloxy)Quinolin-3-Yl)Methylene)Amino)Benzenethiol Schiff base metal complexes</article-title>. <source>Chem. Data Collect.</source> <volume>27</volume>, <fpage>100372</fpage>&#x2013;<lpage>100376</lpage>. <pub-id pub-id-type="doi">10.1016/j.cdc.2020.100372</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aslkhademi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Noshiranzadeh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sadjadi</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Mehrani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Farhadyar</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Synthesis, crystal structure and investigation of the catalytic and spectroscopic properties of a Zn(II) complex with coumarin-hydrazone ligand</article-title>. <source>Polyhedron</source> <volume>160</volume>, <fpage>115</fpage>&#x2013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.poly.2018.12.023</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atasever Arslan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kaya</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>&#x15e;ahin</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Baday</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saylan</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Ulkuseven</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The iron(III) and nickel(II) complexes with tetradentate thiosemicarbazones. Synthesis, experimental, theoretical characterization, and antiviral effect against SARS-CoV-2</article-title>. <source>J. Mol. Struct.</source> <volume>1246</volume>, <fpage>131166</fpage>&#x2013;<lpage>131167</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2021.131166</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balajee</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Srinivasadesikan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sakthivadivel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gunasekaran</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>
<italic>In silico</italic> screening, alanine mutation, and DFT approaches for identification of NS2B/NS3 protease inhibitors</article-title>. <source>Biochem. Res. Int.</source> <volume>2016</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1155/2016/7264080</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becke</surname>
<given-names>A. D.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Density-functional thermochemistry. III. The role of exact exchange</article-title>. <source>J. Chem. Phys.</source> <volume>98</volume>, <fpage>5648</fpage>&#x2013;<lpage>5652</lpage>. <pub-id pub-id-type="doi">10.1063/1.464913</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belkhir-Talbi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ghemmit-Doulache</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Terrachet-Bouaziz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Makhloufi-Chebli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rabahi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ismaili</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Transition-metal complexes of N, N&#x2032;-di(4-bromophenyl)-4-hydroxycoumarin-3-carboximidamide: Synthesis, characterization, biological activities, ADMET and drug-likeness analysis</article-title>. <source>Inorg. Chem. Commun.</source> <volume>127</volume>, <fpage>108509</fpage>&#x2013;<lpage>108512</lpage>. <pub-id pub-id-type="doi">10.1016/j.inoche.2021.108509</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bitew</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Desalegn</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Demissie</surname>
<given-names>T. B.</given-names>
</name>
<name>
<surname>Belayneh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Endale</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eswaramoorthy</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study</article-title>. <source>PLoS One</source> <volume>16</volume>, <fpage>02608533</fpage>&#x2013;<lpage>e260922</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0260853</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Bursey</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>1974</year>). <source>Mass spectrometry of inorganic and organometallic compounds</source>. </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandra</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Spectral and magnetic studies on manganese(II), cobalt(II) and nickel(II) complexes with Schiff bases</article-title>. <source>Spectrochimica Acta Part A Mol. Biomol. Spectrosc.</source> <volume>61</volume>, <fpage>219</fpage>&#x2013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2004.03.036</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cond&#xe9;</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Da</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sodre</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>J. C. F.</given-names>
</name>
<name>
<surname>Navarro</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Synthesis , characterization and antileishmanial activity of copper ( II ) and zinc ( II ) complexes with diamine ligands</article-title>. <source>Transit. Mater. Chem.</source> <volume>47</volume>, <fpage>147</fpage>&#x2013;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1007/s11243-022-00495-7</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Michielin</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Zoete</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules</article-title>. <source>Sci. Rep.</source> <volume>7</volume>, <fpage>42717</fpage>&#x2013;<lpage>42813</lpage>. <pub-id pub-id-type="doi">10.1038/srep42717</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="other">
<collab>Dalal M Charge Transfer Spectra</collab> in <source>A textbook of inorganic chemistry</source> (<publisher-loc>Rohtak, Haryana, India</publisher-loc>: <publisher-name>Dalal Institute</publisher-name>), <fpage>214</fpage>&#x2013;<lpage>341</lpage>.</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Damena</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Alem</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Zeleke</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Desalegn</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Eswaramoorthy</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Demissie</surname>
<given-names>T. B.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Novel zinc ( II ) and copper ( II ) complexes of 2 - (( 2- hydroxyethyl ) amino ) quinoline-3-carbaldehyde for antibacterial and antioxidant activities : A combined experimental , DFT , and docking studies</article-title>. <source>ACS Omega</source> <volume>7</volume>, <fpage>26336</fpage>&#x2013;<lpage>26352</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.2c02205</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Damena</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tesema</surname>
<given-names>T. E.</given-names>
</name>
<name>
<surname>Alvi</surname>
<given-names>N. I.</given-names>
</name>
<name>
<surname>Siraj</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Effect of pyridoxine on the transport of iron across microfilter supported bilayer lipid membrane</article-title>. <source>J. Surfaces Interfaces Mater.</source> <volume>1</volume>, <fpage>130</fpage>&#x2013;<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1166/jsim.2013.1016</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Damena</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zeleke</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Desalegn</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Demissie</surname>
<given-names>T. B.</given-names>
</name>
<name>
<surname>Eswaramoorthy</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Synthesis, characterization, and biological activities of novel vanadium(IV) and cobalt(II) complexes</article-title>. <source>ACS Omega</source> <volume>7</volume>, <fpage>4389</fpage>&#x2013;<lpage>4404</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.1c06205</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demissie</surname>
<given-names>T. B.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>J. H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Mechanism and site selectivity in visible-light photocatalyzed C-H functionalization: Insights from DFT calculations</article-title>. <source>J. Org. Chem.</source> <volume>81</volume>, <fpage>7110</fpage>&#x2013;<lpage>7120</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.6b00977</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demissie</surname>
<given-names>T. B.</given-names>
</name>
<name>
<surname>Sundar</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Thangavel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Andrushchenko</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bedekar</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Bour</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Origins of optical activity in an oxo-helicene: Experimental and computational studies</article-title>. <source>ACS Omega</source> <volume>6</volume>, <fpage>2420</fpage>&#x2013;<lpage>2428</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.0c06079</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Digafie</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Melaku</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Belay</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Eswaramoorthy</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>) <article-title>Synthesis , molecular docking analysis , and evaluation of antibacterial and antioxidant properties of stilbenes and pinacol of quinolines</article-title>. <source>Adv. Pharmacol. Pharm. Sci.</source> <volume>2021</volume>, <fpage>1</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1155/2021/6635270</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ekennia</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Onwudiwe</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Olasunkanmi</surname>
<given-names>L. O.</given-names>
</name>
<name>
<surname>Osowole</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Ebenso</surname>
<given-names>E. E.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Synthesis, DFT calculation, and antimicrobial studies of novel Zn(II), Co(II), Cu(II), and Mn(II) heteroleptic complexes containing benzoylacetone and dithiocarbamate</article-title>. <source>Bioinorg. Chem. Appl.</source> <volume>2015</volume>, <fpage>1</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1155/2015/789063</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Gammal</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Rezk</surname>
<given-names>G. N.</given-names>
</name>
<name>
<surname>El-Bindary</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Synthesis, characterization, catalytic, DNA binding and antibacterial activities of Co(II), Ni(II) and Cu(II) complexes with new Schiff base ligand</article-title>. <source>J. Mol. Liq.</source> <volume>326</volume>, <fpage>115223</fpage>&#x2013;<lpage>115317</lpage>. <pub-id pub-id-type="doi">10.1016/j.molliq.2020.115223</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Metwaly</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Althagafi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Khedr</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Al-Fahemi</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Katouah</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Hossan</surname>
<given-names>A. S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Synthesis and characterization for novel Cu(II)-thiazole complexes-dyes and their usage in dyeing cotton to be special bandage for cancerous wounds</article-title>. <source>J. Mol. Struct.</source> <volume>1194</volume>, <fpage>86</fpage>&#x2013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2019.05.080</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Sonbati</surname>
<given-names>A. Z.</given-names>
</name>
<name>
<surname>Diab</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Eldesoky</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Salem</surname>
<given-names>O. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Polymer complexes. LXXVI. Synthesis, characterization, CT-DNA binding, molecular docking and thermal studies of sulfoxine polymer complexes</article-title>. <source>Appl. Organomet. Chem.</source> <volume>33</volume>, <fpage>48399</fpage>&#x2013;<lpage>e4922</lpage>. <pub-id pub-id-type="doi">10.1002/aoc.4839</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Sonbati</surname>
<given-names>A. Z.</given-names>
</name>
<name>
<surname>Diab</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Abou-Dobara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>El-Ghettany</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Synthesis, characterization, theoretical and molecular docking studies of mixed-ligand complexes of Cu(II), Ni(II), Co(II), Mn(II), Cr(III), UO2(II) and Cd(II)</article-title>. <source>J. Mol. Struct.</source> <volume>1200</volume>, <fpage>127065</fpage>&#x2013;<lpage>127117</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2019.127065</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fetoh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>El-Gammal</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Abu El-Reash</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Antioxidant and antitumor activities of Cr(III), Mn(II), Fe(III), Cd(II), Zn(II) and Hg(II) complexes containing a carbohydrazone ligand ending by 4-pyridyl ring</article-title>. <source>J. Mol. Struct.</source> <volume>1173</volume>, <fpage>100</fpage>&#x2013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2018.06.087</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fouda</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Halogenated 2-amino-4H-pyrano[3, 2-h]quinoline-3-carbonitriles as antitumor agents and structure&#x2013;activity relationships of the 4-6-and 9-positions</article-title>. <source>Med. Chem. Res.</source> <volume>26</volume>, <fpage>302</fpage>&#x2013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1007/s00044-016-1747-z</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Frisch</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Trucks</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Schlegel Ges</surname>
<given-names>H. B.</given-names>
</name>
<name>
<surname>Robb</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Cheeseman</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Scalmani Vb</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <source>Gaussian 16, revision C. 01</source>. <publisher-loc>Wallingford CT</publisher-loc>: <publisher-name>Gaussian, Inc</publisher-name>. </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grimme</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Calculation of the electronic spectra of large molecules</article-title>. <source>Rev. Comput. Chem.</source> <volume>20</volume>, <fpage>153</fpage>&#x2013;<lpage>218</lpage>. </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xfc;veli</surname>
<given-names>&#x15e;.</given-names>
</name>
<name>
<surname>Koca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>&#xd6;zdemir</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bal-Demirci</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ulkuseven</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Electrochemistry and structural properties of new mixed ligand nickel(II) complexes based on thiosemicarbazone</article-title>. <source>New J. Chem.</source> <volume>38</volume>, <fpage>5582</fpage>&#x2013;<lpage>5589</lpage>. <pub-id pub-id-type="doi">10.1039/c4nj00556b</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halevas</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mavroidi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pelecanou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hatzidimitriou</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Structurally characterized zinc complexes of flavonoids chrysin and quercetin with antioxidant potential</article-title>. <source>Inorganica Chim. Acta</source> <volume>523</volume>, <fpage>120407</fpage>&#x2013;<lpage>120411</lpage>. <pub-id pub-id-type="doi">10.1016/j.ica.2021.120407</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamdani</surname>
<given-names>H. E. L.</given-names>
</name>
<name>
<surname>Amane</surname>
<given-names>M. E. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Preparation, spectral, antimicrobial properties and anticancer molecular docking studies of new metal complexes [M(caffeine) 4 ] (PF 6 ) 2; M &#x3d; Fe(II), Co(II), Mn(II), Cd(II), Zn(II), Cu(II), Ni(II)</article-title>. <source>J. Mol. Struct.</source> <volume>1184</volume>, <fpage>262</fpage>&#x2013;<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2019.02.049</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamdani</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Hameed</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Akhter</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ayub</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Synthesis, crystal structures, computational studies and &#x3b1;-amylase inhibition of three novel 1, 3, 4-oxadiazole derivatives</article-title>. <source>J. Mol. Struct.</source> <volume>1200</volume>, <fpage>127085</fpage>&#x2013;<lpage>127089</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2019.127085</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussein</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Elkhair</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19</article-title>. <source>J. Mol. Struct.</source> <volume>1231</volume>, <fpage>129979</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2021.129979</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ilhan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Baykara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Oztomsuk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Okumus</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Levent</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Salih Seyitoglu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Synthesis and characterization of 1, 2-bis(2-(5-bromo-2- hydroxybenzilidenamino)-4-chlorophenoxy)ethane and its metal complexes: An experimental, theoretical, electrochemical, antioxidant and antibacterial study</article-title>. <source>Spectrochimica Acta Part A Mol. Biomol. Spectrosc.</source> <volume>118</volume>, <fpage>632</fpage>&#x2013;<lpage>642</lpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2013.08.069</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Indira</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vinoth</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bharathi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shanmuga Bharathi</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Synthesis, spectral, electrochemical, <italic>in-vitro</italic> antimicrobial and antioxidant activities of bisphenolic mannich base and 8-hydroxyquinoline based mixed ligands and their transition metal complexes</article-title>. <source>J. Mol. Struct.</source> <volume>1198</volume>, <fpage>126886</fpage>&#x2013;<lpage>126888</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2019.126886</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ismael</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Abdel-Mawgoud</surname>
<given-names>A. M. M.</given-names>
</name>
<name>
<surname>Rabia</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Abdou</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Design and synthesis of three Fe(III) mixed-ligand complexes: Exploration of their biological and phenoxazinone synthase-like activities</article-title>. <source>Inorganica Chim. Acta</source> <volume>505</volume>, <fpage>119443</fpage>&#x2013;<lpage>119511</lpage>. <pub-id pub-id-type="doi">10.1016/j.ica.2020.119443</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kargar</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ardakani</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Tahir</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Ashfaq</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Munawar</surname>
<given-names>K. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Synthesis, spectral characterization, crystal structure and antibacterial activity of nickel(II), copper(II) and zinc(II) complexes containing ONNO donor Schiff base ligands</article-title>. <source>J. Mol. Struct.</source> <volume>1233</volume>, <fpage>130112</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2021.130112</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaya</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Er&#xe7;a&#x11f;</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>U&#x11f;uz</surname>
<given-names>&#xd6;.</given-names>
</name>
<name>
<surname>Koca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zorlu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hacioglu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>New asymmetric bisthiocarbohydrazones and their mixed ligand nickel(II) complexes: Synthesis, characterization, crystal structure, electrochemical-spectroelectrochemical property, antimicrobial and antioxidant activity</article-title>. <source>Polyhedron</source> <volume>207</volume>, <fpage>115372</fpage>&#x2013;<lpage>115410</lpage>. <pub-id pub-id-type="doi">10.1016/j.poly.2021.115372</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Khojasteh</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hop</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2011</year>). <source>Drug metabolism and pharmacokinetics quick guide</source>. </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kole&#x161;a-Dobravc</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Maejima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Meden</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yasui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Perdih</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Bis(picolinato) complexes of vanadium and zinc as potential antidiabetic agents: Synthesis, structural elucidation and: <italic>In vitro</italic> insulin-mimetic activity study</article-title>. <source>New J. Chem.</source> <volume>42</volume>, <fpage>3619</fpage>&#x2013;<lpage>3632</lpage>. <pub-id pub-id-type="doi">10.1039/c7nj04189f</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krasnovskaya</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Naumov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Guk</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gorelkin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Erofeev</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Beloglazkina</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Copper coordination compounds as biologically active agents</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume>, <fpage>3965</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21113965</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krishnan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Binkley</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Seeger</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pople</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>1980</year>). <article-title>Self-consistent molecular orbital methods. XX. A basis set for correlated wave functions</article-title>. <source>J. Chem. Phys.</source> <volume>72</volume>, <fpage>650</fpage>&#x2013;<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1063/1.438955</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sati</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hota</surname>
<given-names>P. K.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Antioxidant properties of ethenyl indole: DPPH assay and TDDFT studies</article-title>. <source>New J. Chem.</source> <volume>44</volume>, <fpage>8960</fpage>&#x2013;<lpage>8970</lpage>. <pub-id pub-id-type="doi">10.1039/d0nj01317j</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Parr</surname>
<given-names>R. G.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density</article-title>. <source>Phys. Rev. B</source> <volume>37</volume>, <fpage>785</fpage>&#x2013;<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1103/PhysRevB.37.785</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lipinski</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dominy</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Feeney</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</article-title>. <source>Adv. Drug Deliv. Rev.</source> <volume>64</volume>, <fpage>4</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2012.09.019</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahmoud</surname>
<given-names>W. H.</given-names>
</name>
<name>
<surname>Mahmoud</surname>
<given-names>N. F.</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>G. G.</given-names>
</name>
<name>
<surname>El-Sonbati</surname>
<given-names>A. Z.</given-names>
</name>
<name>
<surname>El-Bindary</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Synthesis, spectroscopic, thermogravimetric and antimicrobial studies of mixed ligands complexes</article-title>. <source>J. Mol. Struct.</source> <volume>1095</volume>, <fpage>15</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2015.04.004</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malik</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Raza</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mohammed</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wani</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Al-Bogami</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Hashmi</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Unravelling the anticancer potential of a square planar copper complex : Toward non-platinum chemotherapy</article-title>. <source>RSC Adv.</source> <volume>11</volume>, <fpage>39349</fpage>&#x2013;<lpage>39361</lpage>. <pub-id pub-id-type="doi">10.1039/D1RA06227A</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandewale</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Kokate</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Thorat</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sawant</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamgar</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Zinc complexes of hydrazone derivatives bearing 3, 4-dihydroquinolin-2(1H)-one nucleus as new anti-tubercular agents</article-title>. <source>Arab. J. Chem.</source> <volume>12</volume>, <fpage>4479</fpage>&#x2013;<lpage>4489</lpage>. <pub-id pub-id-type="doi">10.1016/j.arabjc.2016.07.016</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mogana</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Adhikari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tzar</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Ramliza</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wiart</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Antibacterial activities of the extracts, fractions and isolated compounds from canarium patentinervium miq. Against bacterial clinical isolates</article-title>. <source>BMC Complement. Med. Ther.</source> <volume>20</volume>, <fpage>55</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-020-2837-5</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>El-Sonbati</surname>
<given-names>A. Z.</given-names>
</name>
<name>
<surname>Eissa</surname>
<given-names>H. R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Geometrical structures, thermal properties and spectroscopic studies of Schiff base complexes: Correlation between ionic radius of metal complexes and DNA binding</article-title>. <source>J. Mol. Liq.</source> <volume>240</volume>, <fpage>752</fpage>&#x2013;<lpage>776</lpage>. <pub-id pub-id-type="doi">10.1016/j.molliq.2017.05.114</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murugavel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Stephen</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Subashini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>AnanthaKrishnan</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Synthesis, structural elucidation, antioxidant, CT-DNA binding and molecular docking studies of novel chloroquinoline derivatives: Promising antioxidant and anti-diabetic agents</article-title>. <source>J. Photochem. Photobiol. B Biol.</source> <volume>173</volume>, <fpage>216</fpage>&#x2013;<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1016/j.jphotobiol.2017.05.043</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagesh</surname>
<given-names>G. Y.</given-names>
</name>
<name>
<surname>Mahendra Raj</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mruthyunjayaswamy</surname>
<given-names>B. H. M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Synthesis, characterization, thermal study and biological evaluation of Cu(II), Co(II), Ni(II) and Zn(II) complexes of Schiff base ligand containing thiazole moiety</article-title>. <source>J. Mol. Struct.</source> <volume>1079</volume>, <fpage>423</fpage>&#x2013;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2014.09.013</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Uddin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ullah</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Haider</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gul</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Faisal</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Homo- and heteroleptic Zinc(II) carboxylates: Synthesis, structural characterization, and assessment of their biological significance in <italic>in vitro</italic> models</article-title>. <source>Inorganica Chim. Acta</source> <volume>511</volume>, <fpage>119849</fpage>&#x2013;<lpage>119912</lpage>. <pub-id pub-id-type="doi">10.1016/j.ica.2020.119849</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pearson</surname>
<given-names>R. G.</given-names>
</name>
</person-group> (<year>1968</year>). <article-title>Hard and soft acids and bases, HSAB, part 1: Fundamental principles</article-title>. <source>J. Chem. Educ.</source> <volume>45</volume>, <fpage>581</fpage>&#x2013;<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1021/ed045p581</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinz</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Voss</surname>
<given-names>G. T.</given-names>
</name>
<name>
<surname>Vogt</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Sacramento</surname>
<given-names>M. d.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>7-Chloro-4-phenylsulfonyl quinoline, a new antinociceptive and anti-inflammatory molecule: Structural improvement of a quinoline derivate with pharmacological activity</article-title>. <source>Regul. Toxicol. Pharmacol.</source> <volume>90</volume>, <fpage>72</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.yrtph.2017.08.014</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramachandran</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gandin</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bertani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sgarbossa</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Natarajan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bhuvanesh</surname>
<given-names>N. S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Synthesis, characterization and cytotoxic activity of novel copper(II) complexes with aroylhydrazone derivatives of 2-Oxo-1, 2-dihydrobenzo[h]quinoline-3-carbaldehyde</article-title>. <source>J. Inorg. Biochem.</source> <volume>182</volume>, <fpage>18</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2018.01.016</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramachandran</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Senthil Raja</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bhuvanesh</surname>
<given-names>N. S. P.</given-names>
</name>
<name>
<surname>Natarajan</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Synthesis, characterization and <italic>in vitro</italic> pharmacological evaluation of new water soluble Ni(II) complexes of 4N-substituted thiosemicarbazones of 2-oxo-1, 2-dihydroquinoline-3-carbaldehyde</article-title>. <source>Eur. J. Med. Chem.</source> <volume>64</volume>, <fpage>179</fpage>&#x2013;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2013.03.059</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramesh</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Daravath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Swathi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sumalatha</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Shiva Shankar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shivaraj</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Investigation on Co(II), Ni(II), Cu(II) and Zn(II) complexes derived from quadridentate salen-type Schiff base: Structural characterization, DNA interactions, antioxidant proficiency and biological evaluation</article-title>. <source>Chem. Data Collect.</source> <volume>28</volume>, <fpage>100434</fpage>&#x2013;<lpage>100517</lpage>. <pub-id pub-id-type="doi">10.1016/j.cdc.2020.100434</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ram&#xed;rez&#x2013;Prada</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Robledo</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>V&#xe9;lez</surname>
<given-names>I. D.</given-names>
</name>
<name>
<surname>Crespo</surname>
<given-names>M. D. P.</given-names>
</name>
<name>
<surname>Quiroga</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Abonia</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Synthesis of novel quinoline&#x2013;based 4, 5&#x2013;dihydro&#x2013;1H&#x2013;pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents</article-title>. <source>Eur. J. Med. Chem.</source> <volume>131</volume>, <fpage>237</fpage>&#x2013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2017.03.016</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Refat</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>El-Sayed</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>A. M. A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Cu(II), Co(II) and Ni(II) complexes of new Schiff base ligand: Synthesis, thermal and spectroscopic characterizations</article-title>. <source>J. Mol. Struct.</source> <volume>1038</volume>, <fpage>62</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2013.01.059</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rigsby</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>A. B.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Using the PyMOL application to reinforce visual understanding of protein structure</article-title>. <source>Biochem. Mol. Biol. Educ.</source> <volume>44</volume>, <fpage>433</fpage>&#x2013;<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1002/bmb.20966</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sallam</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Orabi</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Abbas</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>DNA interaction with octahedral and square planar Ni(II) complexes of aspartic-acid Schiff-bases</article-title>. <source>J. Mol. Struct.</source> <volume>1006</volume>, <fpage>272</fpage>&#x2013;<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2011.09.020</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sathisha</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Revankar</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Pai</surname>
<given-names>K. S. R.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Synthesis, structure, electrochemistry, and spectral characterization of bis-isatin thiocarbohydrazone metal complexes and their antitumor activity against ehrlich ascites carcinoma in Swiss Albino mice</article-title>. <source>Mater. Based. Drugs</source> <volume>2008</volume>, <fpage>1</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1155/2008/362105</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Senthil</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bhuvanesh</surname>
<given-names>N. S. P.</given-names>
</name>
<name>
<surname>Natarajan</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Synthesis , crystal structure and pharmacological evaluation of two new Cu ( II ) complexes of 2-oxo-1 , 2-dihydroquinoline-3-carbaldehyde ( benzoyl ) hydrazone : A comparative investigation</article-title>. <source>Eur. J. Med. Chem.</source> <volume>47</volume>, <fpage>73</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2011.10.024</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shalaby</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Determination of stoichiometry and stability constants of iron complexes of phenanthroline , Tris ( 2 - pyridyl )- s - triazine , and salicylate using a digital camera</article-title>. <source>Chem. Pap.</source> <volume>74</volume>, <fpage>3589</fpage>&#x2013;<lpage>3595</lpage>. <pub-id pub-id-type="doi">10.1007/s11696-020-01192-4</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stephens</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Chabalowski</surname>
<given-names>C. F.</given-names>
</name>
<name>
<surname>Frisch</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>
<italic>Ab initio</italic> calculation of vibrational absorption and circular dichroism spectra using density functional force fields</article-title>. <source>J. Phys. Chem.</source> <volume>98</volume>, <fpage>11623</fpage>&#x2013;<lpage>11627</lpage>. <pub-id pub-id-type="doi">10.1021/j100096a001</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sumalatha</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Daravath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rambabu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ramesh</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Antioxidant, antimicrobial, DNA binding and cleavage studies of novel Co(II), Ni(II) and Cu(II) complexes of N, O donor Schiff bases: Synthesis and spectral characterization</article-title>. <source>J. Mol. Struct.</source> <volume>1229</volume>, <fpage>129606</fpage>&#x2013;<lpage>129614</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2020.129606</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szemik-Hojniak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Deperasi&#x144;ska</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nizhnik</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jerzykiewicz</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Luminescent properties of chameleon-like metal-organic framework between zinc(II) dichloride and two quinoline-N-oxide molecules</article-title>. <source>Spectrochimica Acta Part A Mol. Biomol. Spectrosc.</source> <volume>239</volume>, <fpage>118464</fpage>&#x2013;<lpage>118468</lpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2020.118464</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomasi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mennucci</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cammi</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Quantum mechanical continuum solvation models</article-title>. <source>Chem. Rev.</source> <volume>105</volume>, <fpage>2999</fpage>&#x2013;<lpage>3094</lpage>. <pub-id pub-id-type="doi">10.1021/cr9904009</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tyagi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saraswat</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2015</year>) <article-title>Design, spectral characterization, thermal, DFT studies and anticancer cell line activities of Co(II), Ni(II) and Cu(II) complexes of Schiff bases derived from 4-amino-5-(pyridin-4-yl)-4H-1, 2, 4-triazole-3-thiol</article-title>. <source>Spectrochimica Acta Part A Mol. Biomol. Spectrosc.</source> <volume>145</volume>:<fpage>155</fpage>&#x2013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2015.03.034</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Structural characterization, DFT studies and luminescent properties of dinuclear copper(I)-diimine complexes with the S-shape configurations</article-title>. <source>Inorganica Chim. Acta</source> <volume>529</volume> (<issue>1&#x2013;8</issue>), <fpage>120639</fpage>. <pub-id pub-id-type="doi">10.1016/j.ica.2021.120639</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname>
<given-names>B. Q.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>Q. P.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>Y. X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Three novel transition metal complexes of 6-methyl-2-oxo-quinoline-3-carbaldehyde thiosemicarbazone: Synthesis, crystal structure, cytotoxicity, and mechanism of action</article-title>. <source>RSC Adv.</source> <volume>7</volume>, <fpage>17923</fpage>&#x2013;<lpage>17933</lpage>. <pub-id pub-id-type="doi">10.1039/c7ra00826k</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>